Dementia has become rampant among human beings who are pushed into a deep mental abyss, devoid of memories and remembrance. It has been termed as "the long goodbye".

Dementia has become rampant among human beings who are pushed into a deep mental abyss, devoid of memories and remembrance. It has been termed as "the long goodbye". Even though the person remains alive, memories fade away slowly and irreversibly due to dementia. Dementia eventually snatches away the ability of a person to communicate, eat and drink on their own, recognise family members and understand where they are. From the 19th century, caregivers and health-care workers have described people suffering from dementia as becoming lucid. Healthcare workers say that such people were engaging in meaningful conversations, making jokes, sharing memories which were assumed to have been lost, and even asking for meals. Also Read: Does obesity really increase risk of dementia or is it the opposite? According to the study, an estimated 43 per cent of people go through brief lucidity and then die within 24 hours, and 84 per cent die within a week. Here's why this occurs? The term "terminal lucidity" was coined by researchers Michael Nahm and Bruce Greyson in 2009 since it was registered that such lucid episodes often occurred just before death. However, studies suggest that not all such lucid episodes indicate that death is imminent. As per one study, many people suffering from advanced dementia have shown brief memories of their own selves more than six months before dying. There have also been reports of cases of lucidity in other conditions such as meningitis and schizophrenia - which affect the thinking skills or the brain - and in people who have brain tumours or have sustained a brain injury. The moments of lucidity which do not necessarily indicate death are sometimes called paradoxical lucidity. They are considered as paradoxical as it goes against the expected course of neurodegenerative diseases like dementia. However, such episodes of lucidity are temporary and do not hint at any reversal of neurodegenerative disease. Scientists struggle to find cause of terminal lucidity Scientists have been struggling to explain why terminal lucidity occurs. Few episodes of lucidity were noted to have occurred when the patient's loved ones were around him or her. Some studies have also hinted at music improving lucidity. Watch: London's 'light into life' exhibition inspired by nature and science However, many episodes of lucidity do not have a distinct trigger. New York University's research team has speculated that changes in brain activity before death may lead to terminal lucidity. Notably, not everyone with advanced dementia experiences episodes of lucidity just before death. (With inputs from agencies)

Scientists decode why memories come back to some dementia patients before death

People are typically counselled to keep a healthy weight in order to lower their risk of dementia. However, other research indicates that obesity may potentially offer a defence against dementia.

People are typically counselled to keep a healthy weight in order to lower their risk of dementia. However, other research indicates that obesity may potentially offer a defence against dementia. What is the truth behind it? Understanding the link At first glance, the research that links obesity to dementia seems solid. It is generally accepted that obesity throughout middle age raises the risk of dementia in later life. Obesity harms the brain's small blood arteries and is a key contributor to diabetes, high blood pressure, and chronic inflammation—all conditions that have been repeatedly associated with an increased risk of dementia. Exploring the 'obesity paradox' However, if dementia is indeed caused by obesity, then why have dementia rates declined in the west in recent decades while the number of obese individuals has increased? An "obesity paradox" wherein being fat seems to be related with a lower risk of dementia, has been shown in a number of studies. Due to data constraints, scientists find it difficult to establish a cause-and-effect link. While a randomised experiment would be ideal, but assigning people to be obese is unethical. The majority of research is based on observational studies, which include long-term follow-up on large populations. However, these studies may be biased. "Reverse causation" is an issue, especially when researching elderly persons. People in the early stages of dementia may lose weight as a result of the condition, rather than the reverse. This may explain the obesity paradox. Also read: Changes in eyesight linked to early signs of Alzheimer’s and dementia: Study Another issue is called "confounding bias." A third factor associated with both obesity and dementia might explain the apparent relationship between the two. One example is childhood intelligence, which is rarely assessed in these research. Researchers found that although there was a clear association between higher levels of obesity and lower cognitive skills in midlife, this probably wasn't because one was causing the other. Researchers discovered that, while there was a strong link between greater levels of obesity and decreased cognitive skills in midlife, it was unlikely that one caused the other. Instead, it was probably because a third component (childhood intelligence) was linked to both. To summarise, the research of obesity and dementia is complicated. While maintaining a healthy weight is beneficial to general health, the relationship to dementia risk is uncertain. (With inputs from agencies)

Does obesity really increase risk of dementia or is it the opposite?

Your eyes can reveal a lot about your brain health. According to new research, changes in one's visual sensitivity can indicate signs of dementia around 12 years earlier than the official diagnosis.

Your eyes can reveal a lot about your brain health. According to new research, changes in one's visual sensitivity can indicate signs of dementia around 12 years earlier than the official diagnosis. How did the researchers conduct this study? Researchers followed 8,623 healthy individuals in Norfolk, England, for several years. Among them, 537 developed dementia. By analysing the data from the study, researchers identified factors that might precede a dementia diagnosis. The visual sensitivity test Researchers gave the participants a visual sensitivity test at the start of the study. The test required them to identify a triangle among moving dots. The ones who were slower to spot the triangle later developed dementia. Visual signs of dementia Visual issues could be a warning sign of cognitive decline. Alzheimer's disease first affects areas of the brain linked to vision before damaging memory-related regions, according to studies. Thus, vision tests could detect signs of memory disorders. Alzheimer's also affects contrast sensitivity and the ability to discern colours may be impacted early on. These impairments can affect daily life without immediate awareness. One early sign of Alzheimer's is difficulty in controlling eye movements, especially in ignoring distracting stimuli. This issue might increase the risk of accidents, particularly while driving. People with dementia may struggle to process new faces efficiently. They may not follow the usual pattern of scanning a person's face during conversation, making them seem distant or lost. Eye movement could help improve memory Studies suggest that eye movement might enhance memory performance. Watching TV or reading, activities involving frequent eye movements could potentially lower the risk of dementia. What are some limitations of this study? Despite promising findings, using eye movements as a diagnostic tool for Alzheimer's faces challenges. Access to expensive and complex eye-tracking technologies remains a barrier. Until more accessible options are available, widespread use of eye movements in diagnosis remains limited.

Changes in eyesight linked to early signs of Alzheimer’s and dementia: Study

Blood tests are set to begin across the UK to see if dementia can be accurately diagnosed through blood tests. Teams from Oxford University and the University of College London have been commissioned to research the use of cheap and simple tests to detect the disease.

UK: Thousands to trial blood tests for dementia

A new study has revealed that the size of human brains is getting larger, which means increased brain reserve and decreased chances of developing dementia. The researchers at UC Davis Health reached the conclusion by comparing the size of the brains of people born in the 1930s with those of people born in the 1970s. They noticed that the latter had 6.6 per cent larger brains. The study was published in JAMA Neurology.

"The decade someone is born appears to impact brain size and potentially long-term brain health," said Charles DeCarli, first author of the study.

He further adds that genetics may also play a major role in determining the size of the brain. "Genetics plays a major role in determining brain size, but our findings indicate external influences -- such as health, social, cultural and educational factors -- may also play a role," he said.

<h2>How was the study conducted?</h2>

Researchers used brain magnetic resonance imaging (MRIs) from participants in the Framingham Heart Study (FHS). This community-based data was launched in 1948 in Framingham, Massachusetts to analyse patterns of heart diseases.

The original sample size was made up of 5,209 men and women between the ages of 30 and 62. The research continued for 75 years and later included second and third generations of participants.

Then, the MRIs were conducted between 1999 and 2019. The brain study was done on 3,226 participants (53 per cent female, 47 per cent male) with an average age of about 57 at the time of the MRI.

<h2>Result</h2>

For participants born in the 1930s, the average volume of the brain was found to be 1,234 millilitres but for those born in the 1970s, the volume turned out to be 1,321 millilitres, 6.6 per cent larger.

Also read:&nbsp;<a data-ved="2ahUKEwjg17_n_5GFAxWdb2wGHVuHBDAQxfQBKAB6BAgHEAE" href="https://www.wionews.com/science/chronic-fatigue-syndrome-is-biological-key-study-confirms-703678" jsname="YKoRaf" ping="/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.wionews.com/science/chronic-fatigue-syndrome-is-biological-key-study-confirms-703678&amp;ved=2ahUKEwjg17_n_5GFAxWdb2wGHVuHBDAQxfQBKAB6BAgHEAE">Chronic Fatigue Syndrome is `biological`, key study confirms</a>

The researchers found brain structures such as white matter, grey matter and hippocampus (a brain region involved in learning and memory) also increased in size.

<h2>Benefits of larger brain size</h2>

Researchers said it might lead to decreased chances of developing dementia in ageing population.

"Larger brain structures like those observed in our study may reflect improved brain development and improved brain health," DeCarli said.

"A larger brain structure represents a larger brain reserve and may buffer the late-life effects of age-related brain diseases like Alzheimer's and related dementias," he added.

(With inputs from agencies)

A new study has revealed that the size of human brains is getting larger, which means increased brain reserve and decreased chances of developing dementia. The researchers at UC Davis Health reached the conclusion by comparing the size of the brains of people born in the 1930s with those of people born in the 1970s.

A new study has revealed that the size of human brains is getting larger, which means increased brain reserve and decreased chances of developing dementia. The researchers at UC Davis Health reached the conclusion by comparing the size of the brains of people born in the 1930s with those of people born in the 1970s. They noticed that the latter had 6.6 per cent larger brains. The study was published in JAMA Neurology. "The decade someone is born appears to impact brain size and potentially long-term brain health," said Charles DeCarli, first author of the study. He further adds that genetics may also play a major role in determining the size of the brain. "Genetics plays a major role in determining brain size, but our findings indicate external influences -- such as health, social, cultural and educational factors -- may also play a role," he said. How was the study conducted? Researchers used brain magnetic resonance imaging (MRIs) from participants in the Framingham Heart Study (FHS). This community-based data was launched in 1948 in Framingham, Massachusetts to analyse patterns of heart diseases. The original sample size was made up of 5,209 men and women between the ages of 30 and 62. The research continued for 75 years and later included second and third generations of participants. Then, the MRIs were conducted between 1999 and 2019. The brain study was done on 3,226 participants (53 per cent female, 47 per cent male) with an average age of about 57 at the time of the MRI. Result For participants born in the 1930s, the average volume of the brain was found to be 1,234 millilitres but for those born in the 1970s, the volume turned out to be 1,321 millilitres, 6.6 per cent larger. Also read: Chronic Fatigue Syndrome is `biological`, key study confirms The researchers found brain structures such as white matter, grey matter and hippocampus (a brain region involved in learning and memory) also increased in size. Benefits of larger brain size Researchers said it might lead to decreased chances of developing dementia in ageing population. "Larger brain structures like those observed in our study may reflect improved brain development and improved brain health," DeCarli said. "A larger brain structure represents a larger brain reserve and may buffer the late-life effects of age-related brain diseases like Alzheimer's and related dementias," he added. (With inputs from agencies)

Human brains getting larger in size, and this may be good news for some

Former talk show host Wendy Williams has been diagnosed with the same form of dementia that actor Bruce Willis has, a statement released Thursday on behalf of her caretakers says.

The statement said the 59-year-old’s diagnoses of primary progressive aphasia and frontotemporal dementia “have already presented significant hurdles in Wendy’s life” and have behavioural and cognitive impacts.

“Wendy is still able to do many things for herself. Most importantly she maintains her trademark sense of humor and is receiving the care she requires to make sure she is protected and that her needs are addressed. She is appreciative of the many kind thoughts and good wishes being sent her way,” the statement attributed to her care team said.

The statement on Williams’ health was issued on PR Newswire. A representative listed on the release, Jennifer Hanley, referred questions back to the statement when contacted by The Associated Press.

The announcement came a day after a cover story in People magazine quoted Williams’ family about the nature of her struggles, ahead of a Lifetime documentary set to air Saturday.

“The people who love her cannot see her,” People quoted Williams’ sister Wanda as saying. “I think the big (question) is: How the hell did we get here?” The family said a court-appointed legal guardian was the only person with unfettered access to Williams.

The article said the Lifetime documentary crew, which set out in 2022 to chronicle Williams’ comeback, stopped filming in April 2023 when her manager “and jeweller” Will Selby says in footage for the film, she entered a facility to treat “cognitive issues.” Her son says in the documentary that doctors had connected her cognitive issues to alcohol use, People reported.

Her family told People they don’t know where she is and cannot call her themselves, but she can call them.

The Association for Frontotemporal Degeneration describes FTD as a group of brain disorders caused by degeneration of the frontal and/or temporal lobes of the brain that affects behaviour, language and movement. Aphasia, a brain disorder that can lead to problems speaking or understanding words, can be a symptom of it. The association describes frontotemporal degeneration as “an inevitable decline in functioning,” with an average life expectancy of seven to 13 years after the onset of symptoms.

FTD usually occurs in people in their 40s, 50s and early 60s. It can affect a person’s personality, causing a loss of inhibition or inappropriate behaviour. It is sometimes mistaken for depression or bipolar disorder and can take years to diagnose.

There are no treatments to slow or stop the disease, but some interventions can help manage symptoms.

The association was involved in the disclosure of Willis’ diagnosis in February 2023, hosting a statement posted by the actor’s family.

“We thank Wendy Williams for having the courage to make her diagnosis public and raise awareness of the disease,” association CEO Susan Dickinson said in a statement. “We know that a diagnosis like this can be heartbreaking, but she is not alone. While there may not be a cure, every day we are working to improve care and research into treatments for this disease.”

Thursday’s statement credited Weill Cornell Medicine in New York with the care and expertise Williams received. Weill Cornell declined to comment.

Williams rose to fame in part due to her no-boundaries approach to her life, which included sharing personal details about her health, plastic surgery and cocaine addiction — the subject of her 2003 memoir, “Wendy’s Got the Heat.”

A hallmark of The Wendy Williams Show, which competed for viewers with Ellen DeGeneres’ show, was her signature phrase, “How you doin’?” She transitioned to television after a successful career as a radio host, known for her hot takes on gossip and skewering of celebrities, including a contentious 2003 interview with Whitney Houston.

In 2022, Williams’ self-titled daytime talk show ended because of her ongoing health issues. Sherri Shepherd, who filled in for Williams as a guest host, received her own show.

Williams said in 2018 that she had been diagnosed years before with Graves’ disease, which leads to the overproduction of thyroid hormones and can cause wide-ranging symptoms and affect overall health.

Former talk show host Wendy Williams has been diagnosed with the same form of dementia that actor Bruce Willis has, a statement released Thursday on behalf of her caretakers says.

Former talk show host Wendy Williams has been diagnosed with the same form of dementia that actor Bruce Willis has, a statement released Thursday on behalf of her caretakers says. The statement said the 59-year-old’s diagnoses of primary progressive aphasia and frontotemporal dementia “have already presented significant hurdles in Wendy’s life” and have behavioural and cognitive impacts. “Wendy is still able to do many things for herself. Most importantly she maintains her trademark sense of humor and is receiving the care she requires to make sure she is protected and that her needs are addressed. She is appreciative of the many kind thoughts and good wishes being sent her way,” the statement attributed to her care team said. The statement on Williams’ health was issued on PR Newswire. A representative listed on the release, Jennifer Hanley, referred questions back to the statement when contacted by The Associated Press. The announcement came a day after a cover story in People magazine quoted Williams’ family about the nature of her struggles, ahead of a Lifetime documentary set to air Saturday. “The people who love her cannot see her,” People quoted Williams’ sister Wanda as saying. “I think the big (question) is: How the hell did we get here?” The family said a court-appointed legal guardian was the only person with unfettered access to Williams. The article said the Lifetime documentary crew, which set out in 2022 to chronicle Williams’ comeback, stopped filming in April 2023 when her manager “and jeweller” Will Selby says in footage for the film, she entered a facility to treat “cognitive issues.” Her son says in the documentary that doctors had connected her cognitive issues to alcohol use, People reported. Her family told People they don’t know where she is and cannot call her themselves, but she can call them. The Association for Frontotemporal Degeneration describes FTD as a group of brain disorders caused by degeneration of the frontal and/or temporal lobes of the brain that affects behaviour, language and movement. Aphasia, a brain disorder that can lead to problems speaking or understanding words, can be a symptom of it. The association describes frontotemporal degeneration as “an inevitable decline in functioning,” with an average life expectancy of seven to 13 years after the onset of symptoms. FTD usually occurs in people in their 40s, 50s and early 60s. It can affect a person’s personality, causing a loss of inhibition or inappropriate behaviour. It is sometimes mistaken for depression or bipolar disorder and can take years to diagnose. There are no treatments to slow or stop the disease, but some interventions can help manage symptoms. The association was involved in the disclosure of Willis’ diagnosis in February 2023, hosting a statement posted by the actor’s family. “We thank Wendy Williams for having the courage to make her diagnosis public and raise awareness of the disease,” association CEO Susan Dickinson said in a statement. “We know that a diagnosis like this can be heartbreaking, but she is not alone. While there may not be a cure, every day we are working to improve care and research into treatments for this disease.” Thursday’s statement credited Weill Cornell Medicine in New York with the care and expertise Williams received. Weill Cornell declined to comment. Williams rose to fame in part due to her no-boundaries approach to her life, which included sharing personal details about her health, plastic surgery and cocaine addiction — the subject of her 2003 memoir, “Wendy’s Got the Heat.” A hallmark of The Wendy Williams Show, which competed for viewers with Ellen DeGeneres’ show, was her signature phrase, “How you doin’?” She transitioned to television after a successful career as a radio host, known for her hot takes on gossip and skewering of celebrities, including a contentious 2003 interview with Whitney Houston. In 2022, Williams’ self-titled daytime talk show ended because of her ongoing health issues. Sherri Shepherd, who filled in for Williams as a guest host, received her own show. Williams said in 2018 that she had been diagnosed years before with Graves’ disease, which leads to the overproduction of thyroid hormones and can cause wide-ranging symptoms and affect overall health.

Wendy Williams diagnosed with same form of dementia as Bruce Willis

Researchers are hopeful that a blood test could soon enable doctors to predict dementia in patients more than a decade before it is formally identified. The hopes were raised after scientists detected biological markers linked to dementia in blood samples collected from 50,000 healthy individuals in the UK.

The scientists were able to identify patterns of four proteins that indicated the emergence of dementia in patients of older age.

Overall, the protein profiles enabled scientists to predict dementia in patients with a remarkable 90 per cent accuracy. “We hope to develop this as a screening kit that can be used in the NHS,” said Prof Jianfeng Feng, who holds posts at the University of Warwick and Fudan University in China.

<h2>Why is this significant?</h2>

Recent studies have highlighted the potential of blood tests in identifying individuals at risk of developing dementia. Armed with this knowledge, doctors could prioritise certain patients for further evaluations, including comprehensive diagnostic testing for Alzheimer's disease.

Early confirmation of the disease is essential for patients to benefit from two new Alzheimer's drugs, lecanemab and donanemab, currently under review by the UK medicines regulator.

The National Institute for Health and Care Excellence will assess the cost-effectiveness of these drugs before considering their availability through the NHS.

Watch:&nbsp;UK based JET lab achieves historic nuclear fusion breakthrough

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/uk-based-jet-lab-achieves-historic-nuclear-fusion-breakthrough-689009/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

While lecanemab has been approved by the US Food and Drug Administration and donanemab's approval is imminent, European regulators are still evaluating both medications.

<h2>Concerns over use of the drugs</h2>

Lecanemab, a synthetic antibody therapy developed by Biogen in the US and Eisai in Japan, gained attention in 2022 for its ability to slow Alzheimer's progression. However, concerns have also been raised by doctors and medical charities regarding the readiness of healthcare services to administer such treatments.

Also read:&nbsp;<a data-jsarwt="1" data-usg="AOvVaw1XMcB-U64uk6rQZe9UcHxU" data-ved="2ahUKEwj8ncvrsaaEAxUITmwGHcFNCPMQxfQBKAB6BAgOEAE" href="https://www.wionews.com/science/frequently-nose-picking-leading-cause-of-progressive-dementia-study-687765" jsname="YKoRaf">Frequent nose-picking leading cause of progressive dementia: Study</a>

To be eligible for lecanemab or donanemab, patients must have early-stage Alzheimer's and undergo a lumbar puncture or PET scan to confirm the presence of amyloid protein in the brain, a characteristic hallmark of Alzheimer's disease.

However, Alzheimer's Research UK estimates that only two per cent of eligible patients undergo such testing.

(With inputs from agencies)

Researchers are hopeful that a blood test could soon enable doctors to predict dementia in patients more than a decade before it is formally identified. The hopes were raised after scientists detected biological markers linked to dementia in blood samples collected from 50,000 healthy individuals in the UK.

Researchers are hopeful that a blood test could soon enable doctors to predict dementia in patients more than a decade before it is formally identified. The hopes were raised after scientists detected biological markers linked to dementia in blood samples collected from 50,000 healthy individuals in the UK. The scientists were able to identify patterns of four proteins that indicated the emergence of dementia in patients of older age. Overall, the protein profiles enabled scientists to predict dementia in patients with a remarkable 90 per cent accuracy. “We hope to develop this as a screening kit that can be used in the NHS,” said Prof Jianfeng Feng, who holds posts at the University of Warwick and Fudan University in China. Why is this significant? Recent studies have highlighted the potential of blood tests in identifying individuals at risk of developing dementia. Armed with this knowledge, doctors could prioritise certain patients for further evaluations, including comprehensive diagnostic testing for Alzheimer's disease. Early confirmation of the disease is essential for patients to benefit from two new Alzheimer's drugs, lecanemab and donanemab, currently under review by the UK medicines regulator. The National Institute for Health and Care Excellence will assess the cost-effectiveness of these drugs before considering their availability through the NHS. Watch: UK based JET lab achieves historic nuclear fusion breakthrough × While lecanemab has been approved by the US Food and Drug Administration and donanemab's approval is imminent, European regulators are still evaluating both medications. Concerns over use of the drugs Lecanemab, a synthetic antibody therapy developed by Biogen in the US and Eisai in Japan, gained attention in 2022 for its ability to slow Alzheimer's progression. However, concerns have also been raised by doctors and medical charities regarding the readiness of healthcare services to administer such treatments. Also read: Frequent nose-picking leading cause of progressive dementia: Study To be eligible for lecanemab or donanemab, patients must have early-stage Alzheimer's and undergo a lumbar puncture or PET scan to confirm the presence of amyloid protein in the brain, a characteristic hallmark of Alzheimer's disease. However, Alzheimer's Research UK estimates that only two per cent of eligible patients undergo such testing. (With inputs from agencies)

Scientists close to developing blood test for detecting dementia a decade early

People who frequently pick their noses are highly likely to develop&nbsp;Alzheimer’s disease, a new study has revealed. The study was conducted by reviewing dozens of published research papers. Researchers at Western Sydney University found that nose-picking introduces certain germs into the nasal cavity, which trigger the brain to produce beta-amyloid as a defence mechanism.

Scientists believe beta-amyloid is a leading cause of the progressive dementia that characterizes Alzheimer’s disease. “Neuroinflammation in [Alzheimer’s disease] might be partially caused by pathogens entering the brain through the olfactory system,” the researchers concluded.

"The olfactory system represents a plausible route for pathogen entry, given its direct anatomical connection to the brain and its involvement in the early stages of AD,” the report explained.

<h2>USA’s Alzheimer's problem</h2>

According to the Mayo Clinic, approximately 6.5 million individuals aged 65 and above in the United States have Alzheimer's disease, with over 70 per cent of these cases occurring in individuals aged 75 and older. This progressive brain disorder is the most prevalent form of dementia.

Watch:&nbsp;Gravitas: New drug claims to slow down Alzheimer's disease

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-new-drug-claims-to-slow-down-alzheimers-disease-617195/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

Globally, Alzheimer's disease is believed to account for up to 70 per cent of the 55 million people living with dementia. The USA’s National Institute on Aging suggests that its onset may result from a combination of age-related brain changes, genetic predispositions, environmental factors, and lifestyle choices.

While various lifestyle factors may contribute to Alzheimer's disease, the authors of the report caution against nose-picking, even though removing dried mucus can aid in easier breathing.

Also read:&nbsp;<a data-jsarwt="1" data-usg="AOvVaw1wZBoTxlw2y3-bondZJOnv" data-ved="2ahUKEwj_y-XB2piEAxUGSGwGHf37AAMQxfQBKAB6BAgHEAE" href="https://www.wionews.com/science/strong-link-found-between-alzheimers-disease-and-intake-of-processed-food-study-686418" jsname="YKoRaf">Strong link found between Alzheimer's disease and intake of processed food: Study</a>

“It is essential to note that the temporary relief obtained from nose picking is not a substitute for proper nasal hygiene, which involves regular cleaning and maintenance of the nasal passages through gentle methods such as saline nasal rinses or blowing the nose,” the report said.

“One of the lessons learned from COVID-19 is the value of hand hygiene through frequent hand washing and the use of hand sanitisers, and we suggest these routine hygienic procedures be mandatory routine procedures for the incurable nose-picker,” the report added.

(With inputs from agencies)

People who frequently pick their noses are highly likely to develop Alzheimer’s disease, a new study has revealed. The study was conducted by reviewing dozens of published research papers.

People who frequently pick their noses are highly likely to develop Alzheimer’s disease, a new study has revealed. The study was conducted by reviewing dozens of published research papers. Researchers at Western Sydney University found that nose-picking introduces certain germs into the nasal cavity, which trigger the brain to produce beta-amyloid as a defence mechanism. Scientists believe beta-amyloid is a leading cause of the progressive dementia that characterizes Alzheimer’s disease. “Neuroinflammation in [Alzheimer’s disease] might be partially caused by pathogens entering the brain through the olfactory system,” the researchers concluded. "The olfactory system represents a plausible route for pathogen entry, given its direct anatomical connection to the brain and its involvement in the early stages of AD,” the report explained. USA’s Alzheimer's problem According to the Mayo Clinic, approximately 6.5 million individuals aged 65 and above in the United States have Alzheimer's disease, with over 70 per cent of these cases occurring in individuals aged 75 and older. This progressive brain disorder is the most prevalent form of dementia. Watch: Gravitas: New drug claims to slow down Alzheimer's disease × Globally, Alzheimer's disease is believed to account for up to 70 per cent of the 55 million people living with dementia. The USA’s National Institute on Aging suggests that its onset may result from a combination of age-related brain changes, genetic predispositions, environmental factors, and lifestyle choices. While various lifestyle factors may contribute to Alzheimer's disease, the authors of the report caution against nose-picking, even though removing dried mucus can aid in easier breathing. Also read: Strong link found between Alzheimer's disease and intake of processed food: Study “It is essential to note that the temporary relief obtained from nose picking is not a substitute for proper nasal hygiene, which involves regular cleaning and maintenance of the nasal passages through gentle methods such as saline nasal rinses or blowing the nose,” the report said. “One of the lessons learned from COVID-19 is the value of hand hygiene through frequent hand washing and the use of hand sanitisers, and we suggest these routine hygienic procedures be mandatory routine procedures for the incurable nose-picker,” the report added. (With inputs from agencies)

Frequent nose-picking leading cause of progressive dementia: Study

Humans have long been drawn to scents and fragrances, so much so that the scent industry has now gone beyond just the perfumes. You have various types of diffusers, essential oils, candles, incense and a lot more.

Humans have long been drawn to scents and fragrances, so much so that the scent industry has now gone beyond just the perfumes. You have various types of diffusers, essential oils, candles, incense and a lot more. If you haven't given in yet to the love for sweet-smelling things, you now have a major reason to do so. Fragrances and scents can have a positive impact on our memory, especially on senior citizens, a new study has shown. In fact, burning the night diffuser and filling up the bedroom with some scintillating scents can lower the risk of dementia immensely. How do scents help? Neurologically, scent triggers memories because the brain processes scent in the amygdala and hippocampus, the areas of emotional and episodic memories. In a trial at the University of California, Irvine, neuroscientists found that senior citizens saw a jump in cognitive performance by 226 per cent after using fragrance diffusers in their bedrooms every night for two hours, reported Psychology Today. They performed the trial on 43 adults aged between 60 and 85 with no prior diagnosis of cognitive impairment or dementia. The neuroscientists distributed commercially bought scent diffusers containing seven essential oil cartridges of rose, orange, eucalyptus, lemon, peppermint, rosemary, and lavender. They gave 20 trial participants a full-strength fragrance cartridge. The other 23 received cartridges with only small amounts of odorant as a control group. The trial participants had to use a cartridge in the diffuser every night before sleeping to spread the scent as they slept. ALSO READ | Storm on Mars: UAE probe detects significant dust mobilisation According to the previous research, patients with dementia had improved memory and language skills when exposed to 40 odours twice daily. However, the researchers at California University Irvine designed the trial differently because they thought it was unrealistic to ask senior citizens with cognitive impairment to open, sniff, and close bottles 80 times daily. Cynthia Woo, the study's lead author, said, "That's why we reduced the number of scents to only seven, exposing participants to just one each time, rather than the multiple aromas used simultaneously in previous research projects." She added, "By making it possible for people to experience the odours while sleeping, we eliminated the need to set aside time for this during waking hours every day." After six months, the research revealed that members of the scent-enriched group performed better than the control group in a word list test. The word list test evaluated verbal learning, retention, and recognition memory. Moreover, they reported having better sleep. Furthermore, MRI scans of the scent-enriched group revealed they had better integrity in the left uncinate fasciculus, a brain pathway connecting parts of the limbic system which weakens with age. Thus, the study established that scent can enhance memory power if used in a non-invasive intervention and prevent dementia in senior citizens. (With inputs from agencies)

Lighting up that scent diffuser can improve your memory power, study finds

Does having a good sense of smell also mean good cognitive health? US' National Institute of Aging have found an answer to this question - research has found that there is a link between sense of smell and Dementia especially in older adults.

Is sense of smell linked to cognitive health? | Sense of smell, bio-marker for Dementia, says study

In older persons, having a keen sense of smell is linked to a slower rate of brain volume loss and cognitive decline. This relationship between scent and brain and cognitive alterations may be particularly strong in those who have dementia or cognitive impairment.

Is sense of smell linked to cognitive health?

A recent report from the Dementia Commission reveals that approximately 36 per cent of individuals in England with dementia are unaware of their condition.

Dementia encompasses various diseases, such as Alzheimer's, causing issues with memory, reasoning, communication, personality changes, and a decline in daily activities.

Dementia manifests uniquely in each person, making it crucial to discern what is normal for your loved one.

Age-related cognitive changes and the impact of grief and stress can affect memory, but a consistent pattern of decline over weeks or days should prompt urgent medical investigation.

Recognising signs of dementia involves observing symptoms that impact a person's ability to function at work or in day-to-day tasks.

These signs encompass a decline in previous levels of functioning, memory loss not explained by psychiatric disorders, and cognitive and behavioural impairments such as difficulty acquiring new information, impaired decision-making, and changes in personality.

<a href="https://www.wionews.com/science/scientists-reveal-11-dementia-risk-factors-that-could-determine-who-all-are-at-risk-629154">Also read |&nbsp;Scientists reveal 11 dementia risk factors that could determine who all are at risk</a>

<h2>Diverse dementia-related diseases</h2>

Dementia is a prevalent condition affecting one in eight adults over 65 and 46 per cent&nbsp;of those over 85. Various diseases fall under the dementia umbrella, including Alzheimer's disease, vascular dementia, dementia with Lewy bodies, mixed dementia, Parkinson's disease, frontotemporal lobar degeneration, Creutzfeldt-Jakob disease, and normal pressure hydrocephalus.

Memory loss can result from Alzheimer's disease, stroke, trauma, brain tumors, alcohol abuse, diseases like HIV, and depression, with the most common form being Alzheimer's, constituting 50 to 70 per cent&nbsp;of dementia cases.&nbsp;

Certain memory-related symptoms are part of the normal aging process and not indicative of dementia. These include responding to clues or multiple-choice options despite memory impairment, minor delays in word finding, retaining visuospatial function, retaining social skills, and no change in daily activities.

<a href="https://www.wionews.com/science-tech/ai-can-help-detect-dementia-way-before-than-doctors-claims-oxford-professor-646330">Also read |&nbsp;AI can help detect dementia way before doctors do, claims Oxford professor</a>

Diagnosing dementia involves MRI, neuropsychological testing, and a comprehensive medical history review. While there is currently no cure, medications can help manage symptoms temporarily.

Understanding the normal ageing process is crucial, as some memory-related changes are expected and not necessarily linked to dementia. Differentiating between normal ageing and potential dementia symptoms aids in providing appropriate care and support.

(With inputs from agencies)

A recent report from the Dementia Commission reveals that approximately 36 per cent of individuals in England with dementia are unaware of their condition. Dementia encompasses various diseases, such as Alzheimer's, causing issues with memory, reasoning, communication, personality changes, and a decline in daily activities.

A recent report from the Dementia Commission reveals that approximately 36 per cent of individuals in England with dementia are unaware of their condition. Dementia encompasses various diseases, such as Alzheimer's, causing issues with memory, reasoning, communication, personality changes, and a decline in daily activities. Dementia manifests uniquely in each person, making it crucial to discern what is normal for your loved one. Age-related cognitive changes and the impact of grief and stress can affect memory, but a consistent pattern of decline over weeks or days should prompt urgent medical investigation. Recognising signs of dementia involves observing symptoms that impact a person's ability to function at work or in day-to-day tasks. These signs encompass a decline in previous levels of functioning, memory loss not explained by psychiatric disorders, and cognitive and behavioural impairments such as difficulty acquiring new information, impaired decision-making, and changes in personality. Also read | Scientists reveal 11 dementia risk factors that could determine who all are at risk Diverse dementia-related diseases Dementia is a prevalent condition affecting one in eight adults over 65 and 46 per cent of those over 85. Various diseases fall under the dementia umbrella, including Alzheimer's disease, vascular dementia, dementia with Lewy bodies, mixed dementia, Parkinson's disease, frontotemporal lobar degeneration, Creutzfeldt-Jakob disease, and normal pressure hydrocephalus. Memory loss can result from Alzheimer's disease, stroke, trauma, brain tumors, alcohol abuse, diseases like HIV, and depression, with the most common form being Alzheimer's, constituting 50 to 70 per cent of dementia cases. Certain memory-related symptoms are part of the normal aging process and not indicative of dementia. These include responding to clues or multiple-choice options despite memory impairment, minor delays in word finding, retaining visuospatial function, retaining social skills, and no change in daily activities. Also read | AI can help detect dementia way before doctors do, claims Oxford professor Diagnosing dementia involves MRI, neuropsychological testing, and a comprehensive medical history review. While there is currently no cure, medications can help manage symptoms temporarily. Understanding the normal ageing process is crucial, as some memory-related changes are expected and not necessarily linked to dementia. Differentiating between normal ageing and potential dementia symptoms aids in providing appropriate care and support. (With inputs from agencies)

Nearly 40% of dementia patients are unaware of their condition: Study

Former US first lady Rosalynn Carter, wife of ex-President Jimmy Carter, died ‘peacefully’ on Sunday (Nov 19) at the age of 96. Last week, she was shifted to a hospice care home in the state of Georgia.&nbsp;

There, she had been spending time with her 99-year-old husband, who has been there since February.

Earlier in May this year, she was diagnosed with dementia.

“Rosalynn was my equal partner in everything I ever accomplished,” Jimmy Carter said in a statement released Sunday afternoon by the Carter Center.

“She gave me wise guidance and encouragement when I needed it. As long as Rosalynn was in the world, I always knew somebody loved and supported me.”

The statement said Mrs Carter died “peacefully, with family by her side.”

<h2>Rosalynn Carter’s early life</h2>

Born as Eleanor Rosalynn Smith in August 1927 in Plains, a small rural town with fewer than 600 residents, the former first lady even had her hometown in common with her husband.

Watch:&nbsp;US: Blinken asks Israel for urgent action against settler violence in West Bank

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/us-blinken-asks-israel-for-urgent-action-against-settler-violence-in-west-bank-world-news-wion-659555/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

A steadfast supporter throughout his political journey, she remained by his side in the White House and continued her loyalty during his post-presidential years as a respected international diplomat after his single term concluded in 1981.&nbsp;

<h2>Rosalynn Carter’s contribution to society</h2>

Yet, she also carved out her own path, championing mental health advocacy and engaging in social justice activism.

In 1987, she established the Rosalynn Carter Institute for Caregivers, actively participating in the organisation well into her later years.&nbsp;

The Carter Center, a human rights non-profit founded by the couple, acknowledged her contributions earlier this year when revealing her dementia diagnosis.

<a href="https://www.wionews.com/world/every-living-us-presidents-including-obama-are-descendants-of-slave-owners-except-donald-trump-report-609464">Also read:&nbsp;Every living US president, including Obama, is descendant of slave owners, except Donald Trump: Report</a>

“Mrs Carter has been the nation’s leading mental health advocate for much of her life. We recognize, as she did more than half a century ago, that stigma is often a barrier that keeps individuals and their families from seeking and getting much-needed support,” it said in a statement.

“We hope sharing our family’s news will increase important conversations at kitchen tables and in doctor’s offices around the country.”

Rosalynn Carter and her husband were also supporters of Habitat for Humanity, raising awareness and funds for the Carter Work Project named for them, and frequently tackling projects themselves as “some of our best hands-on construction volunteers”.

The couple celebrated their 75th wedding anniversary in 2021 and had four children: Jack, Chip, James and Amy.

(With inputs from agencies)

Former US first lady Rosalynn Carter, wife of ex-President Jimmy Carter, died ‘peacefully’ on Sunday (Nov 19) at the age of 96. Last week, she was shifted to a hospice care home in the state of Georgia.

Former US first lady Rosalynn Carter, wife of ex-President Jimmy Carter, died ‘peacefully’ on Sunday (Nov 19) at the age of 96. Last week, she was shifted to a hospice care home in the state of Georgia. There, she had been spending time with her 99-year-old husband, who has been there since February. Earlier in May this year, she was diagnosed with dementia. “Rosalynn was my equal partner in everything I ever accomplished,” Jimmy Carter said in a statement released Sunday afternoon by the Carter Center. “She gave me wise guidance and encouragement when I needed it. As long as Rosalynn was in the world, I always knew somebody loved and supported me.” The statement said Mrs Carter died “peacefully, with family by her side.” Rosalynn Carter’s early life Born as Eleanor Rosalynn Smith in August 1927 in Plains, a small rural town with fewer than 600 residents, the former first lady even had her hometown in common with her husband. Watch: US: Blinken asks Israel for urgent action against settler violence in West Bank × A steadfast supporter throughout his political journey, she remained by his side in the White House and continued her loyalty during his post-presidential years as a respected international diplomat after his single term concluded in 1981. Rosalynn Carter’s contribution to society Yet, she also carved out her own path, championing mental health advocacy and engaging in social justice activism. In 1987, she established the Rosalynn Carter Institute for Caregivers, actively participating in the organisation well into her later years. The Carter Center, a human rights non-profit founded by the couple, acknowledged her contributions earlier this year when revealing her dementia diagnosis. Also read: Every living US president, including Obama, is descendant of slave owners, except Donald Trump: Report “Mrs Carter has been the nation’s leading mental health advocate for much of her life. We recognize, as she did more than half a century ago, that stigma is often a barrier that keeps individuals and their families from seeking and getting much-needed support,” it said in a statement. “We hope sharing our family’s news will increase important conversations at kitchen tables and in doctor’s offices around the country.” Rosalynn Carter and her husband were also supporters of Habitat for Humanity, raising awareness and funds for the Carter Work Project named for them, and frequently tackling projects themselves as “some of our best hands-on construction volunteers”. The couple celebrated their 75th wedding anniversary in 2021 and had four children: Jack, Chip, James and Amy. (With inputs from agencies)

Rosalynn Carter, ex-US president Jimmy Carter’s wife, dies at 96 months after dementia diagnosis

A recent study has revealed that moderate consumption of tea and coffee can lead to a decrease in risks associated with cognitive disorders such as dementia.

The study, published in Nutrition Reviews indicated that those who consume coffee and tea were 27 per cent and 32 per cent less likely, respectively, to develop cognitive disorders compared to those who don’t.

The researchers at China Medical University led by Ying Zhu and Chun-Xiang arrived at the conclusion after conducting a meta-analysis, which is in essence a large investigation analysing many studies at once.&nbsp;

In total, data from 389,505 participants was analysed, 18,459 of which included cases of cognitive disorders.

<h2>What is moderate consumption?</h2>

The study found that the best results in the case of coffee came at approximately 2.5 cups per day. No better results were observed in those who consumed higher quantities.&nbsp;

Also, it revealed that coffee had no influence on risks associated with cognitive impairment without dementia (CIND).

Watch:&nbsp;Drastic weather change affects the quality and production of coffee

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/drastic-weather-change-affects-the-quality-and-production-of-coffee-640159/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

In the case of tea, the risk of death from cognitive disorders decreased by 11 per cent for those who consumed 1 cup per day.

In another interesting revelation, it was found that while coffee consumption led to a decreased risk of cognitive disorders in white individuals, tea consumption offered more protection to Asian individuals.

Protection was stronger for men than that for women in both coffee and tea consumption.

<h2>Caffeine boosts brain function</h2>

In simpler terms, caffeine offers a temporary boost to brain function while also safeguarding the brain from long-term cognitive issues.&nbsp;

Caffeine achieves this by blocking specific receptors, particularly the adenosine receptors, which tend to become overly active. This blockade enhances signalling and communication in select brain regions, thereby enhancing memory and learning.

<a href="https://www.wionews.com/science/drinking-more-coffee-may-actually-help-you-says-study-646806">Also read:&nbsp;Drinking more coffee may actually help you, says study</a>

It's essential to acknowledge certain limitations. Despite the researchers' efforts to control potential variables that could influence the results, there remains a chance that unmeasured factors like tobacco and alcohol consumption, or income and educational levels, might have had an impact.&nbsp;

All in all, some questions still remain unsolved, that experts might try to address in further investigations.

(With inputs from agencies)

A recent study has revealed that moderate consumption of tea and coffee can lead to a decrease in risks associated with cognitive disorders such as dementia. The study, published in Nutrition Reviews indicated that those who consume coffee and tea were 27 per cent and 32 per cent less likely, respectively, to develop cognitive disorders compared to those who don’t.

A recent study has revealed that moderate consumption of tea and coffee can lead to a decrease in risks associated with cognitive disorders such as dementia. The study, published in Nutrition Reviews indicated that those who consume coffee and tea were 27 per cent and 32 per cent less likely, respectively, to develop cognitive disorders compared to those who don’t. The researchers at China Medical University led by Ying Zhu and Chun-Xiang arrived at the conclusion after conducting a meta-analysis, which is in essence a large investigation analysing many studies at once. In total, data from 389,505 participants was analysed, 18,459 of which included cases of cognitive disorders. What is moderate consumption? The study found that the best results in the case of coffee came at approximately 2.5 cups per day. No better results were observed in those who consumed higher quantities. Also, it revealed that coffee had no influence on risks associated with cognitive impairment without dementia (CIND). Watch: Drastic weather change affects the quality and production of coffee × In the case of tea, the risk of death from cognitive disorders decreased by 11 per cent for those who consumed 1 cup per day. In another interesting revelation, it was found that while coffee consumption led to a decreased risk of cognitive disorders in white individuals, tea consumption offered more protection to Asian individuals. Protection was stronger for men than that for women in both coffee and tea consumption. Caffeine boosts brain function In simpler terms, caffeine offers a temporary boost to brain function while also safeguarding the brain from long-term cognitive issues. Caffeine achieves this by blocking specific receptors, particularly the adenosine receptors, which tend to become overly active. This blockade enhances signalling and communication in select brain regions, thereby enhancing memory and learning. Also read: Drinking more coffee may actually help you, says study It's essential to acknowledge certain limitations. Despite the researchers' efforts to control potential variables that could influence the results, there remains a chance that unmeasured factors like tobacco and alcohol consumption, or income and educational levels, might have had an impact. All in all, some questions still remain unsolved, that experts might try to address in further investigations. (With inputs from agencies)

Moderate consumption of tea, coffee linked to decreased risks of cognitive disorders: Study

The most common risk factors for dementia appeared to have a greater impact on risk for people in minority ethnic groups, a study led by researchers at University College London (UCL) suggested. The study, <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0289893">published in the journal Plos One </a>on Wed (Oct 11), found that modifiable risk factors—including hypertension, obesity, and diabetes among others had different impacts on dementia risk for different ethnic groups. It included 865,674 people with 8,479,973 person-years of follow-up.

"We used anonymised data from English electronic primary care records for adults aged 65 and older between 1997 and 2018," the study said.

The study suggested&nbsp;that not only were some risk factors more common in ethnic minorities, but they also had&nbsp;a greater impact on their risk of developing the disease compared with White people.&nbsp;

The study showed that 12.6% of the study population developed dementia—16% of White people, 8.6% of South Asian people, 12.1% of Black people, and 9.7% of those from other ethnic groups.

"The impact of hypertension, obesity, diabetes, low HDL (high-density lipoprotein) and sleep disorders on dementia risk was increased in South Asian people compared to White people. The impact of hypertension was greater in Black compared to White people," the study said.

"Analyses using hypertension diagnosed prior to age 60, 55 and 50 all gave the same results as hypertension diagnosed before age 65," it added.

The study pointed out that dementia prevention efforts should be targeted towards people from minority ethnic groups and tailored to risk factors of particular importance.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The most common risk factors for dementia appeared to have a greater impact on risk for people in minority ethnic groups, a study led by researchers at University College London (UCL) suggested.

The most common risk factors for dementia appeared to have a greater impact on risk for people in minority ethnic groups, a study led by researchers at University College London (UCL) suggested. The study, published in the journal Plos One on Wed (Oct 11), found that modifiable risk factors—including hypertension, obesity, and diabetes among others had different impacts on dementia risk for different ethnic groups. It included 865,674 people with 8,479,973 person-years of follow-up. "We used anonymised data from English electronic primary care records for adults aged 65 and older between 1997 and 2018," the study said. The study suggested that not only were some risk factors more common in ethnic minorities, but they also had a greater impact on their risk of developing the disease compared with White people. The study showed that 12.6% of the study population developed dementia—16% of White people, 8.6% of South Asian people, 12.1% of Black people, and 9.7% of those from other ethnic groups. "The impact of hypertension, obesity, diabetes, low HDL (high-density lipoprotein) and sleep disorders on dementia risk was increased in South Asian people compared to White people. The impact of hypertension was greater in Black compared to White people," the study said. "Analyses using hypertension diagnosed prior to age 60, 55 and 50 all gave the same results as hypertension diagnosed before age 65," it added. The study pointed out that dementia prevention efforts should be targeted towards people from minority ethnic groups and tailored to risk factors of particular importance. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Study suggests dementia risk factors have greater impact on minority ethnic groups

Bruce Willis' struggle with dementia continues to get tougher. Recently, Bruce's wife, Emma Heming Willis, talked about her husband's health status as she went on to reveal that Bruce's diagnosis had changed the entire family. Weeks later, Moonlighting creator and Bruce's close friend Glenn Gordon Caron is giving an update on Willis’ condition.

On Tuesday, Glenn spoke to the New York Post, and he went on to reveal that Willis' communication has started getting affected, and he's not totally verbal now.

Saying that he often tries to visit the actor and his family, Glenn told the outlet,&nbsp;reports People,&nbsp;“I’m not always quite that good but I try and I do talk to him and his wife [Emma Heming Willis] and I have a casual relationship with his three older children.”&nbsp;

“I have tried very hard to stay in his life.”

“The thing that makes [his disease] so mind-blowing is [that] if you’ve ever spent time with Bruce Willis, there is no one who had any more joie de vivre [joy of living] than he,” the director added further.&nbsp;

He added, “He loved life and … just adored waking up every morning and trying to live life to its fullest.”

Further revealing about Bruce's condition, Caron said that the actor is unable to communicate now, “My sense is the first one to three minutes he knows who I am,” he said before adding,&nbsp;“He’s not totally verbal; he used to be a voracious reader — he didn’t want anyone to know that — and he’s not reading now. All those language skills are no longer available to him, and yet he’s still Bruce.”

“When you’re with him you know that he’s Bruce and you’re grateful that he’s there,” he noted, “but the joie de vivre is gone.”

Caron and Bruce have worked together in the series Moonlighting. In the show, which ran from 1985 - 89, Bruce played the role of David Addison Junior.

Bruce Willis' wife talks about dementia.

On the episode “Today” to bring awareness to the disease during World Frontotemporal Dementia Awareness Week, Emma said that her family’s life has changed since the diagnosis.

“What I’m learning is that dementia is hard,” Emma said. “It’s hard on the person diagnosed. It’s also hard on the family. And that is no different for Bruce, or myself or our girls. When they say that this is a family disease, it really is.”

Bruce Willis has retired from acting

Willis, one of the most-loved actors of the '80s and early 1990s, was diagnosed with frontotemporal dementia in 2022. The actor's family announced his retirement from acting as a result of the diagnosis. 
 
At the time, their statement read, “To Bruce’s amazing supporters, as a family we wanted to share that our beloved Bruce has been experiencing some health issues and has recently been diagnosed with aphasia, which is impacting his cognitive abilities. As a result of this and with much consideration Bruce is stepping away from the career that has meant so much to him.”

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

&nbsp;

Bruce Willis' struggle with dementia continues to get tougher. Recently, Bruce's wife, Emma Heming Willis, talked about her husband's health status as she went on to reveal that Bruce's diagnosis had changed the entire family.

Bruce Willis' struggle with dementia continues to get tougher. Recently, Bruce's wife, Emma Heming Willis, talked about her husband's health status as she went on to reveal that Bruce's diagnosis had changed the entire family. Weeks later, Moonlighting creator and Bruce's close friend Glenn Gordon Caron is giving an update on Willis’ condition. On Tuesday, Glenn spoke to the New York Post, and he went on to reveal that Willis' communication has started getting affected, and he's not totally verbal now. Saying that he often tries to visit the actor and his family, Glenn told the outlet, reports People, “I’m not always quite that good but I try and I do talk to him and his wife [Emma Heming Willis] and I have a casual relationship with his three older children.” “I have tried very hard to stay in his life.” “The thing that makes [his disease] so mind-blowing is [that] if you’ve ever spent time with Bruce Willis, there is no one who had any more joie de vivre [joy of living] than he,” the director added further. He added, “He loved life and … just adored waking up every morning and trying to live life to its fullest.” Further revealing about Bruce's condition, Caron said that the actor is unable to communicate now, “My sense is the first one to three minutes he knows who I am,” he said before adding, “He’s not totally verbal; he used to be a voracious reader — he didn’t want anyone to know that — and he’s not reading now. All those language skills are no longer available to him, and yet he’s still Bruce.” “When you’re with him you know that he’s Bruce and you’re grateful that he’s there,” he noted, “but the joie de vivre is gone.” Caron and Bruce have worked together in the series Moonlighting. In the show, which ran from 1985 - 89, Bruce played the role of David Addison Junior. Bruce Willis' wife talks about dementia. On the episode “Today” to bring awareness to the disease during World Frontotemporal Dementia Awareness Week, Emma said that her family’s life has changed since the diagnosis. “What I’m learning is that dementia is hard,” Emma said. “It’s hard on the person diagnosed. It’s also hard on the family. And that is no different for Bruce, or myself or our girls. When they say that this is a family disease, it really is.” Bruce Willis has retired from acting Willis, one of the most-loved actors of the '80s and early 1990s, was diagnosed with frontotemporal dementia in 2022. The actor's family announced his retirement from acting as a result of the diagnosis. At the time, their statement read, “To Bruce’s amazing supporters, as a family we wanted to share that our beloved Bruce has been experiencing some health issues and has recently been diagnosed with aphasia, which is impacting his cognitive abilities. As a result of this and with much consideration Bruce is stepping away from the career that has meant so much to him.” WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Bruce Willis' battle with dementia: Actor is not totally verbal, reveals Moonlighting creator

The Artificial Intelligence (AI) has made significant changes in the digital world. It can now be game-changing in healthcare as well. A recent study by an Oxford professor suggests that with the help of AI we can detect dementia way before doctors can.&nbsp;

Michael Wooldridge, a professor of computer science at the University of Oxford, said that with the help of our smartphones we will be able to detect early signs of dementia. He explained that technology could spot increased hesitancy in a person while using their device, which is one possible sign of the condition.

Also Read |&nbsp;<a href="https://www.wionews.com/science/over-75-trillion-tonnes-decline-in-antarcticas-ice-shelves-since-1997-half-show-no-sign-of-recovery-646295">Over 7.5 trillion tonnes decline in Antarctica's ice shelves since 1997, half show 'no sign of recovery'</a>

At an event discussing the pros and cons of AI at The Times and Sunday Times Literature Festival, he said he was “very optimistic” about the opportunities it could provide in healthcare. Wooldridge said: “I have colleagues at Oxford that think that AI is going to enable us to identify the onset of dementia, just from the way that people use their mobile phones.”

<h2>AI in healthcare</h2>

AI, if used efficiently and in control, can have huge benefits to healthcare and medical field, Wooldridge said. It is already being used in some settings to help spot early onset dementia by analysing people’s speech patterns and eye movements.&nbsp;

Researchers say these tools will play a significant role in reducing the burden on dementia assessment services. The average waiting time from a dementia referral to receiving a diagnosis increased from 13 weeks in 2019 to 17.7 weeks in 2021, a survey by the Royal College of Psychiatrists found.

<h2>Threats involved</h2>

Wooldridge, however, warned that large language models, such as ChatGPT, could be exploited by hackers to launch cyberattacks. He said bad actors could use chatbots to carry out attacks on institutions including the NHS and the Ministry of Defence by “firing off a huge number of requests to a website”.

Also Read |&nbsp;<a href="https://www.wionews.com/science/software-by-indian-techies-helps-hear-from-distant-galaxies-make-discoveries-646321">Software by Indian techies helps hear from distant galaxies, make discoveries</a>

The denial of service is among the most basic forms of cyberattack, which works by overwhelming servers with an avalanche of bogus requests for data, making it impossible for legitimate web traffic to get through.

“The website just gets drowned and it can’t respond,” Wooldridge said. “Open AI, who produce ChatGPT, will probably try and prevent you from doing that. But within a few years what happens if we have all got a large language model downloaded from the dark web on our laptop or smartphone and there are just no barriers, there are no guardrails to stop that.”

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

&nbsp;

The Artificial Intelligence (AI) has made significant changes in the digital world. It can now be game-changing in healthcare as well. A recent study by an Oxford professor suggests that with the help of AI we can detect dementia way before doctors can.

The Artificial Intelligence (AI) has made significant changes in the digital world. It can now be game-changing in healthcare as well. A recent study by an Oxford professor suggests that with the help of AI we can detect dementia way before doctors can. Michael Wooldridge, a professor of computer science at the University of Oxford, said that with the help of our smartphones we will be able to detect early signs of dementia. He explained that technology could spot increased hesitancy in a person while using their device, which is one possible sign of the condition. Also Read | Over 7.5 trillion tonnes decline in Antarctica's ice shelves since 1997, half show 'no sign of recovery' At an event discussing the pros and cons of AI at The Times and Sunday Times Literature Festival, he said he was “very optimistic” about the opportunities it could provide in healthcare. Wooldridge said: “I have colleagues at Oxford that think that AI is going to enable us to identify the onset of dementia, just from the way that people use their mobile phones.” AI in healthcare AI, if used efficiently and in control, can have huge benefits to healthcare and medical field, Wooldridge said. It is already being used in some settings to help spot early onset dementia by analysing people’s speech patterns and eye movements. Researchers say these tools will play a significant role in reducing the burden on dementia assessment services. The average waiting time from a dementia referral to receiving a diagnosis increased from 13 weeks in 2019 to 17.7 weeks in 2021, a survey by the Royal College of Psychiatrists found. Threats involved Wooldridge, however, warned that large language models, such as ChatGPT, could be exploited by hackers to launch cyberattacks. He said bad actors could use chatbots to carry out attacks on institutions including the NHS and the Ministry of Defence by “firing off a huge number of requests to a website”. Also Read | Software by Indian techies helps hear from distant galaxies, make discoveries The denial of service is among the most basic forms of cyberattack, which works by overwhelming servers with an avalanche of bogus requests for data, making it impossible for legitimate web traffic to get through. “The website just gets drowned and it can’t respond,” Wooldridge said. “Open AI, who produce ChatGPT, will probably try and prevent you from doing that. But within a few years what happens if we have all got a large language model downloaded from the dark web on our laptop or smartphone and there are just no barriers, there are no guardrails to stop that.” (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

AI can help detect dementia way before doctors do, claims Oxford professor

As per a new study, the "good" HDL cholesterol is not as healthy as experts once believed. The new study, which was published in Neurology on Wednesday (Oct 4), discovered that having either high or low levels of high-density lipoprotein or HDL cholesterol increases the risk of dementia in older adults. &nbsp;

The research suggests that there is more evidence which shows it is important to maintain HDL cholesterol within a certain range for cardiovascular and brain health. &nbsp;

“The relationship between HDL cholesterol and dementia is more complex than we previously thought," stated the study’s lead author, Erin Ferguson. Ferguson is a doctoral student pursuing epidemiology at the University of California San Francisco. "While the magnitude of this relationship is relatively small, it’s important,” he added.&nbsp;

ALSO READ |<a href="https://www.wionews.com/science/disease-x-likely-to-prove-20-times-deadlier-compared-to-covid-19-hints-expert-639469">&nbsp;'Disease X' likely to prove 20 times deadlier compared to COVID-19, hints expert</a>

The results of the study showed a correlation between dementia and HDL cholesterol but failed to prove that high or low levels of the lipid directly led to dementia.&nbsp;

The study, which was supported by the National Institutes of Health and the National Institute on Aging, considered more than 184,000 adults with an average age of 70. When the study started, none of the adults had dementia.&nbsp;

<h2>More than 25,000 people developed dementia during study</h2>

The electronic records from the Kaiser Permanente Northern California health plan and a combination of surveys were used by the researchers to track health behaviours, cholesterol levels and if someone developed dementia in a time span of 13 years. &nbsp;

During that period, more than 25,000 people had developed dementia. The Centers for Disease Control and Prevention asked people to maintain their total cholesterol at about 150 mg/dL, with LDL at or below 100 mg/dL. For a long time, low-density lipoprotein, or LDL cholesterol has been believed to have a deadly impact on the cardiovascular system.

WATCH |&nbsp;Gravitas: 'Disease X' could be 20 times deadlier than the Wuhan virus

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-disease-x-could-be-20-times-deadlier-than-the-wuhan-virus-639567/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

The participants of the study were divided into three groups on the basis of their HDL cholesterol levels and other dementia risk factors which included diabetes, high blood pressure, heart disease, diabetes and how often a person drinks. &nbsp;

In the study, the average HDL cholesterol level was 53.7 mg/dL, within the recommended range of 50 mg/dL in women and 40 mg/dL in men.&nbsp;

You can&nbsp;now write for&nbsp;wionews.com&nbsp;and be a part of the community. Share your stories and opinions with us&nbsp;<a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

As per a new study, the "good" HDL cholesterol is not as healthy as experts once believed. The new study, which was published in Neurology on Wednesday (Oct 4), discovered that having either high or low levels of high-density lipoprotein or HDL cholesterol increases the risk of dementia in older adults.

As per a new study, the "good" HDL cholesterol is not as healthy as experts once believed. The new study, which was published in Neurology on Wednesday (Oct 4), discovered that having either high or low levels of high-density lipoprotein or HDL cholesterol increases the risk of dementia in older adults. The research suggests that there is more evidence which shows it is important to maintain HDL cholesterol within a certain range for cardiovascular and brain health. “The relationship between HDL cholesterol and dementia is more complex than we previously thought," stated the study’s lead author, Erin Ferguson. Ferguson is a doctoral student pursuing epidemiology at the University of California San Francisco. "While the magnitude of this relationship is relatively small, it’s important,” he added. ALSO READ | 'Disease X' likely to prove 20 times deadlier compared to COVID-19, hints expert The results of the study showed a correlation between dementia and HDL cholesterol but failed to prove that high or low levels of the lipid directly led to dementia. The study, which was supported by the National Institutes of Health and the National Institute on Aging, considered more than 184,000 adults with an average age of 70. When the study started, none of the adults had dementia. More than 25,000 people developed dementia during study The electronic records from the Kaiser Permanente Northern California health plan and a combination of surveys were used by the researchers to track health behaviours, cholesterol levels and if someone developed dementia in a time span of 13 years. During that period, more than 25,000 people had developed dementia. The Centers for Disease Control and Prevention asked people to maintain their total cholesterol at about 150 mg/dL, with LDL at or below 100 mg/dL. For a long time, low-density lipoprotein, or LDL cholesterol has been believed to have a deadly impact on the cardiovascular system. WATCH | Gravitas: 'Disease X' could be 20 times deadlier than the Wuhan virus The participants of the study were divided into three groups on the basis of their HDL cholesterol levels and other dementia risk factors which included diabetes, high blood pressure, heart disease, diabetes and how often a person drinks. In the study, the average HDL cholesterol level was 53.7 mg/dL, within the recommended range of 50 mg/dL in women and 40 mg/dL in men. You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here. WATCH WION LIVE HERE

'Good' cholesterol not good? HDL deemed a dementia risk, suggests new study

Bruce Willis’s wife Emma Heming Willis recently opened up about the actor’s health status after it was diagnosed that he is suffering from frontotemporal dementia (FTD). Appearing on the Monday episode of “Today” to bring awareness to the disease during World Frontotemporal Dementia Awareness week, Emma said that&nbsp;her family’s life has changed since the diagnosis.&nbsp;

“What I’m learning is that dementia is hard,” Emma said. “It’s hard on the person diagnosed. It’s also hard on the family. And that is no different for Bruce, or myself, or our girls. When they say that this is a family disease, it really is.”

When the host prodded her if he was aware of his surroundings, Emma responded saying, “Hard to know. It’s hard to know.”&nbsp;

<h2>They are still a happy family</h2>

Emma, however, pointed out that there is still plenty of joy in her family, despite the diagnosis. “There are so many beautiful things happening in our lives. It’s just really important for me to look up from the grief and the sadness so that I can see what is happening around us. Bruce would really want us to be in the joy of what is. He would really want that for me and our family,” she said.&nbsp;

<h2>Bruce Willis has retired from acting</h2>

Willis’ family announced his retirement from acting last year as a result of the diagnosis. At the time, their statement read, “To Bruce’s amazing supporters, as a family we wanted to share that our beloved Bruce has been experiencing some health issues and has recently been diagnosed with aphasia, which is impacting his cognitive abilities. As a result of this and with much consideration Bruce is stepping away from the career that has meant so much to him.”

Signs of FTD can include speech issues, difficulty with motor skills like walking, and changes in behaviour and personality. The frontal lobe of the brain, which is impacted by the disease, controls self-insight, which can result in Bruce’s understanding of his situation.&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here.</a>

 
&nbsp;

Bruce Willis’s wife Emma Heming Willis recently opened up about the actor’s health status after it was diagnosed that he is suffering from frontotemporal dementia (FTD).

Bruce Willis’s wife Emma Heming Willis recently opened up about the actor’s health status after it was diagnosed that he is suffering from frontotemporal dementia (FTD). Appearing on the Monday episode of “Today” to bring awareness to the disease during World Frontotemporal Dementia Awareness week, Emma said that her family’s life has changed since the diagnosis. “What I’m learning is that dementia is hard,” Emma said. “It’s hard on the person diagnosed. It’s also hard on the family. And that is no different for Bruce, or myself, or our girls. When they say that this is a family disease, it really is.” When the host prodded her if he was aware of his surroundings, Emma responded saying, “Hard to know. It’s hard to know.” They are still a happy family Emma, however, pointed out that there is still plenty of joy in her family, despite the diagnosis. “There are so many beautiful things happening in our lives. It’s just really important for me to look up from the grief and the sadness so that I can see what is happening around us. Bruce would really want us to be in the joy of what is. He would really want that for me and our family,” she said. Bruce Willis has retired from acting Willis’ family announced his retirement from acting last year as a result of the diagnosis. At the time, their statement read, “To Bruce’s amazing supporters, as a family we wanted to share that our beloved Bruce has been experiencing some health issues and has recently been diagnosed with aphasia, which is impacting his cognitive abilities. As a result of this and with much consideration Bruce is stepping away from the career that has meant so much to him.” Signs of FTD can include speech issues, difficulty with motor skills like walking, and changes in behaviour and personality. The frontal lobe of the brain, which is impacted by the disease, controls self-insight, which can result in Bruce’s understanding of his situation. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

'Dementia is hard', says Bruce Willis' wife while giving an update on actor's health

There's currently no cure known for Alzheimer's disease that causes a decline in memory - thinking, learning and organising skills. Over time it is the most common cause of Dementia and usually affects people over the age of 65.

Japan 1st country to get treatment for Alzheimer's as it approves drug  to treat disease

Every year, we celebrate World Alzheimer's Day on September 21 to create awareness about Alzheimer's disease, also called senile dementia. However, there are other forms of neuro-degenerative dementia, which are often misdiagnosed as Alzheimer's.

Every year, we celebrate World Alzheimer's Day on September 21 to create awareness about Alzheimer's disease, also called senile dementia. However, there are other forms of neuro-degenerative dementia, which are often misdiagnosed as Alzheimer's. Pseudo-dementia is one of them. Pseudo-dementia is a mental condition where a person faces a loss of cognitive abilities. It might appear similar to other forms of neuro-degenerative dementia. However, it's a result of another psychiatric condition, often depression. Psuedo-dementia mimics other forms of dementia without sharing the same physical alterations in brain structure and function. Some experts believe it can be a sign that other forms of dementia will develop later. However, effective treatment can reverse the underlying psychiatric condition. Here's everything you need to know about pseudo-dementia. What are the symptoms of pseudo-dementia? The symptoms of dementia and pseudo-dementia are almost similar. According to Healthline, people with pseudo-dementia have problems with memory, judgement, decision-making, and cognitive function. There are no laboratory tests to identify pseudo-dementia. Experts primarily diagnose it through observation of demeanour or memory changes and neurocognitive testing. Here's a list of people at a higher risk of pseudo-dementia: People with a history of depression or other psychiatric disorders People over the age of 65 People assigned female at birth People who have alcohol or substance use disorders What causes pseudo-dementia? Pseudo-dementia typically conceals a mental disorder that has not been identified or treated. The mental disorders most frequently linked to pseudodementia include depression and major depressive disorder. Other less common mental health disorders associated with pseudo-dementia include psychosis, mania and conversion disorder. How is pseudo-dementia different from dementia? Although dementia and pseudo-dementia look similar, they are different conditions. While changes in brain structure cause dementia, pseudo-dementia develops when an underlying mental health condition remains untreated. People with dementia (Alzheimer's disease) have a significant loss in brain volume, usually a 10 to 50 per cent loss in the hippocampus. Studies suggest that people with Alzheimer's have reductions in both the left and right hippocampus. Meanwhile, people diagnosed with pseudo-dementia only showed a slight decrease in the left hippocampus size. Moreover, dementia begins with short-term memory loss, while pseudo-dementia might impact short-term and long-term memory. Dementia and pseudo-dementia affect the behaviour of a person differently. While people with forms of dementia often try to suppress their setbacks in memory and cognitive function, people with pseudo-dementia highlight their symptoms. Furthermore, pseudo-dementia is a reversible psychiatric condition which can be treated effectively. However, dementia treatment primarily focuses on managing the symptoms. How is pseudo-dementia treated? For the majority of those who acquire pseudo-dementia, treatment with antidepressants and other psychiatric drugs that helped to treat any associated disorders has corrected the cognitive abnormalities. (With inputs from agencies) WATCH WION LIVE HERE

World Alzheimer's Day 2023: What is pseudo-dementia and how is it different from dementia?

Having a greater sense of purpose in life can keep diseases like Alzheimer’s and other dementias away, researchers have found in a new study.

The study has also revealed that following a diagnosis of dementia, a person’s sense of purpose experiences a steady decline.

“Purpose in life is the feeling that one’s life is goal-oriented and has direction. It is an important component of well-being,” Angelina Sutin, lead author of the study published Wednesday in the journal JAMA Network Open, was quoted as saying by CNN.

“Previous studies have found that individuals with more purpose are less likely to develop Alzheimer’s disease and other dementias,” she said in an email.&nbsp;

“Here we look at the relation between purpose and cognitive impairment in the other direction: does impairment have an impact on feeling purposeful?”, she added.

<h2>Data from 30,000 individuals analysed</h2>

To establish the results, researchers examined data from over 30,000 individuals across two distinct studies: the Health and Retirement Study spanning from 2006 to 2021, and the National Health and Aging Trends Study covering the period from 2011 to 2021.

During the study, participants underwent multiple evaluations spanning several years to assess both cognitive impairment and their sense of purpose.

Watch:&nbsp;Scientists reveal how to detect signs of Dementia 9 years before diagnosis

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/scientists-reveal-how-to-detect-signs-of-dementia-9-years-before-diagnosis-550942/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

While there were indications of declining feelings of purpose leading up to cognitive impairment, the decline became notably swifter once impairment was detected, as pointed out by Sutin.

These findings align with existing knowledge about deteriorations in mental well-being following a diagnosis, as noted by Dr Sam Fazio, senior director of quality care and psychosocial research at the Alzheimer’s Association.

<a href="https://www.wionews.com/science/scientists-reveal-11-dementia-risk-factors-that-could-determine-who-all-are-at-risk-629154">Also read:&nbsp;Scientists reveal 11 dementia risk factors that could determine who all are at risk</a>

It's worth noting that the identification of impairment was based on cognitive tasks rather than a diagnosis from a healthcare professional.

Nevertheless, the results hold strong credibility due to the utilisation of assessments spanning over a decade, with consistent trends observed in both study groups.

<h2>Importance of purpose in life</h2>

Experts believe it is critically important for an individual to have a strong sense of purpose in life.&nbsp;

“The opposite of purpose in life — apathy — is a significant problem in dementia. Individuals with dementia lose their drive to engage in life,” Sutin said.&nbsp;

“It is critically important for individuals to maintain their purpose in life to prevent or at least delay this apathy, which can reduce quality of life,” she added.

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

&nbsp;

Having a greater sense of purpose in life can keep diseases like Alzheimer’s and other dementias away, researchers have found in a new study. The study has also revealed that following a diagnosis of dementia, a person’s sense of purpose experiences a steady decline.

Having a greater sense of purpose in life can keep diseases like Alzheimer’s and other dementias away, researchers have found in a new study. The study has also revealed that following a diagnosis of dementia, a person’s sense of purpose experiences a steady decline. “Purpose in life is the feeling that one’s life is goal-oriented and has direction. It is an important component of well-being,” Angelina Sutin, lead author of the study published Wednesday in the journal JAMA Network Open, was quoted as saying by CNN. “Previous studies have found that individuals with more purpose are less likely to develop Alzheimer’s disease and other dementias,” she said in an email. “Here we look at the relation between purpose and cognitive impairment in the other direction: does impairment have an impact on feeling purposeful?”, she added. Data from 30,000 individuals analysed To establish the results, researchers examined data from over 30,000 individuals across two distinct studies: the Health and Retirement Study spanning from 2006 to 2021, and the National Health and Aging Trends Study covering the period from 2011 to 2021. During the study, participants underwent multiple evaluations spanning several years to assess both cognitive impairment and their sense of purpose. Watch: Scientists reveal how to detect signs of Dementia 9 years before diagnosis × While there were indications of declining feelings of purpose leading up to cognitive impairment, the decline became notably swifter once impairment was detected, as pointed out by Sutin. These findings align with existing knowledge about deteriorations in mental well-being following a diagnosis, as noted by Dr Sam Fazio, senior director of quality care and psychosocial research at the Alzheimer’s Association. Also read: Scientists reveal 11 dementia risk factors that could determine who all are at risk It's worth noting that the identification of impairment was based on cognitive tasks rather than a diagnosis from a healthcare professional. Nevertheless, the results hold strong credibility due to the utilisation of assessments spanning over a decade, with consistent trends observed in both study groups. Importance of purpose in life Experts believe it is critically important for an individual to have a strong sense of purpose in life. “The opposite of purpose in life — apathy — is a significant problem in dementia. Individuals with dementia lose their drive to engage in life,” Sutin said. “It is critically important for individuals to maintain their purpose in life to prevent or at least delay this apathy, which can reduce quality of life,” she added. WATCH WION LIVE HERE ×

Not having a sense of purpose in life may lead to dementia: Study

According to a study by a think group funded by the Pentagon, dementia affecting American officials poses a threat to national security as the national security staff ages. The study was published last spring at a time when numerous top American officials who were entrusted with some of the most highly sensitive intelligence in the country made mistakes in public, igniting calls for resignation and discussion about Washington's senile leadership.

Dementia among US officials poses national security threat: Study

Scientists have now revealed 11 risk factors for dementia that can help you predict if someone will develop the condition in the coming years.

This comes as experts have forecast that almost triple to 153 million people by 2050 will be living with dementia globally. However, according to them, almost 40 per cent of cases can be reversed if they target key factors including lifestyle changes like losing weight, reduced alcohol consumption and smoking, the Guardian reported.&nbsp;

The findings were published in the journal BMJ Mental Health. The new dementia score drew 11 factors that could identify people who are at risk or are on the verge of developing it during mid-life. The study was led by the Univeristy of Oxford, which examined people aged 50 to 73 taking part in two long-term British studies — the UK Biobank Study and the Whitehall II study.&nbsp;

For the UK Biobank study, 220,762 people around the age&nbsp;of 60 were examined to develop the risk assessment tool while some 2,934 people&nbsp;aged&nbsp;57 helped to validate the Whiteball II study.&nbsp;

The researchers then compiled a list of 28 unknown factors linked to dementia risk and identified the strongest predictors. They produced 11 predictive factors or the UK Biobank Dementia Risk Score (UKBDRS) tool. These 11 factors are age, education, a history of diabetes, a history of depression, a history of stroke, parental history of dementia, levels of deprivation, high blood pressure, high cholesterol, living alone and gender.

The scientist also examined a specific gene alongside these risk factors called the APOE gene. They found that UBDRS-APOE produced the highest predictive score of dementia.&nbsp;

They also identified those at risk, and how they can use preventive measures for people to avoid the illness.&nbsp;

Lead scientist, Raihaan Patel said, "The UKBDRS may best be used as an initial screening tool to stratify people into risk groups, and those identified as high risk could then benefit from the more time-intensive follow-up assessments described above for more detailed characterisation."

Furthermore, co-lead and associate professor Sana Suri said, "It’s important to remember that this risk score only tells us about our chances of developing dementia; it doesn’t represent a definitive outcome. The importance of each risk factor varies and given that some of the factors included in the score can be modified or treated, there are things we can all do to help reduce our risk of dementia."

(With inputs from agencies) 
 
&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Scientists have now revealed 11 risk factors for dementia that can help you predict if someone will develop the condition in the coming years. This comes as experts have forecast that almost triple to 153 million people by 2050 will be living with dementia globally.

Scientists have now revealed 11 risk factors for dementia that can help you predict if someone will develop the condition in the coming years. This comes as experts have forecast that almost triple to 153 million people by 2050 will be living with dementia globally. However, according to them, almost 40 per cent of cases can be reversed if they target key factors including lifestyle changes like losing weight, reduced alcohol consumption and smoking, the Guardian reported. The findings were published in the journal BMJ Mental Health. The new dementia score drew 11 factors that could identify people who are at risk or are on the verge of developing it during mid-life. The study was led by the Univeristy of Oxford, which examined people aged 50 to 73 taking part in two long-term British studies — the UK Biobank Study and the Whitehall II study. For the UK Biobank study, 220,762 people around the age of 60 were examined to develop the risk assessment tool while some 2,934 people aged 57 helped to validate the Whiteball II study. The researchers then compiled a list of 28 unknown factors linked to dementia risk and identified the strongest predictors. They produced 11 predictive factors or the UK Biobank Dementia Risk Score (UKBDRS) tool. These 11 factors are age, education, a history of diabetes, a history of depression, a history of stroke, parental history of dementia, levels of deprivation, high blood pressure, high cholesterol, living alone and gender. The scientist also examined a specific gene alongside these risk factors called the APOE gene. They found that UBDRS-APOE produced the highest predictive score of dementia. They also identified those at risk, and how they can use preventive measures for people to avoid the illness. Lead scientist, Raihaan Patel said, "The UKBDRS may best be used as an initial screening tool to stratify people into risk groups, and those identified as high risk could then benefit from the more time-intensive follow-up assessments described above for more detailed characterisation." Furthermore, co-lead and associate professor Sana Suri said, "It’s important to remember that this risk score only tells us about our chances of developing dementia; it doesn’t represent a definitive outcome. The importance of each risk factor varies and given that some of the factors included in the score can be modified or treated, there are things we can all do to help reduce our risk of dementia." (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Scientists reveal 11 dementia risk factors that could determine who all are at risk

What can be called a massive breakthrough in the field of fighting Alzheimer's, a research said Monday (July 17) that an experimental medicine from Eli Lilly works best if Alzheimer's patients are treated as early as possible with it.

What can be called a massive breakthrough in the field of fighting Alzheimer's, a research said Monday (July 17) that an experimental medicine from Eli Lilly works best if Alzheimer's patients are treated as early as possible with it. The research, published in JAMA, emerged as a new ray of hope for all those who are suffering from this condition. It says that the medication would ideally help before patients develop symptoms of the brain-wasting disease. This is the latest promising development for treating the most common form of dementia. Alzheimer's is a type of dementia that affects the brain. It slowly destroys memory and thinking skills and the ability to carry out the simplest tasks in day-to-day life. The new trial data was presented at the Alzheimer's Association International Conference in Amsterdam. It stated that the medicine, Donanemab, has been shown to slow the progression of memory and thinking problems by about a third. However, the rate doubles to 60 per cent if it is started when patients are only mildly impaired. Also read: Eli Lilly's new Alzheimer's drug shows promise of slowing down memory decline There's no cure for Alzheimer's or any disease-modifying treatment, but Donanemab has shown positive results in its first trials. The research included over 1,700 patients, and a comprehensive analysis of the trial revealed that results were less robust for older, later-stage individuals, as well as those with greater levels of tau, a protein linked to Alzheimer's disease progression. Anne White, who is the president of neuroscience at Lilly, said that the findings highlight that "earlier detection and diagnosis can really change the trajectory of this disease". Company awaits FDA approval The medicine has not been approved yet, as Lilly expects the US Food and Drug Administration to determine whether to approve Donanemab before the end of this year. The company said that the submissions to additional global regulators are underway and that the majority will be finished by the end of the year. This medication is like the recently approved Eisai and Biogen drug Leqembi, which is an injectable antibody designed to remove deposits of a protein called beta-amyloid from Alzheimer's patient's brains. Dr Susan Kohlhaas, who is the executive director of research and partnerships at Alzheimer's Research UK referred to Lilly's data released on Monday, and said that "these results provide further confirmation that removing amyloid from the brain can change the course of Alzheimer's, and may help people affected by this devastating disease if they're treated at the right time." Also read: Research discovers repair process that fixes damaged hearing cells Are we winning against Alzheimer's? The result is promising, and millions of people who are struggling hope to make their lives better. Maybe not fully, but to help them partially as the brain disorder due to Alzheimer's gets worse over time. While dealing with Alzheimer's, what's important first and foremost is to raise awareness and address the common stigma that surrounds disease-related dementia. A World Health Organization (WHO) published earlier this year in March mentioned that more than 55 million people have dementia worldwide currently, over 60 per cent of whom live in low-and middle-income countries. Every year, there are nearly 10 million new cases. Dementia is caused by a number of diseases and traumas to the brain and Alzheimer's disease is the most common type of dementia, accounting for 60-70 per cent of cases. Dementia is now the seventh largest cause of death and one of the primary causes of impairment and dependency among the world's elderly, WHO said. Maybe we are not winning, but even a positive breakthrough can be massive for those who are losing cognitive functioning and behavioural abilities. Watch this report: × Are there side effects? Lilly's research states that brain swelling, a recognised side effect of amyloid-clearing antibodies, occurred in more than 40 per cent of Alzheimer's patients. According to the company, brain swelling affected 24 per cent of the entire Donanemab treatment group. Brain haemorrhage occurred in approximately 31 per cent of the Donanemab group and around 14 per cent of the placebo group. According to the researchers, the medication was connected to the deaths of three study patients. The study investigator Dr Liana Apostolova, who is a professor in Alzheimer's Disease research at Indiana University School of Medicine, said that "these side effects should not be taken lightly," but most cases were manageable by monitoring with magnetic resonance imaging (MRI) or stopping the medicine. She said that doctors are likely to use "very stringent MRI safety screening while we treat these patients". Donanemab's treatment impact increased relative to the placebo during the duration of the 18-month trial, according to Lilly, even for patients who were taken off the drug after their levels of amyloid deposits dropped dramatically. Meanwhile, White said that "at the end of the trial, the average patient had been without drug for seven months and yet they continued to benefit." She said the findings support the idea that Donanemab can be stopped once amyloid is cleared from the brain. Dr Liz Coulthard, an associate professor in dementia neurology at the University of Bristol, said, "Some patients did not worsen significantly during the trial and on the average progression of disease was slowed 4.4-7.5 months over 18 months." Despite the side effects, some are hopeful. Dr Reisa Sperling, who directs the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital in Boston, said that the latest study "gives me great hope" for the outcomes of those prevention trials. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Explained | Will we defeat Alzheimer's? Why new trial with 60% success is a beacon of hope

A breakthrough drug known as donanemab has emerged as a significant milestone in the battle against chronic forgetfulness or&nbsp;Alzheimer's disease, after a global trial that confirmed its ability to slow down cognitive decline.

The US pharmaceuticals group Eli Lilly on Monday reported full findings of its phase 3 clinical study of donanemab at the Alzheimer’s Association International Conference in Amsterdam. The results showed that&nbsp;the antibody treatment slowed progression by about 35 per cent in the early stages of the disease.

When an individual suffers from dementia, a toxic protein gets accumulated in their brain. The aforementioned medication reportedly aids in the early stages of the disease by eliminating this exact protein.

The donanemab trial involved 1,736 participants with an average age of 73. The trial participants&nbsp;had mild to moderate symptoms of Alzheimer’s, with half receiving intravenous infusions of the treatment and half a placebo every four weeks for 18 months.

The Eli Lilly drug reportedly slowed the progression of the disease, most effectively in its earlier stages.

<h2>So, is it a cure for dementia?</h2>

Not exactly.

While the medication does not provide a cure, various charitable organisations asserted that the findings published in the journal JAMA point to a new era in Alzheimer's treatment.

The treatment specifically targets Alzheimer's disease and does not demonstrate effectiveness in treating other forms of dementia, such as vascular dementia.

<h2>What next for donanemab?</h2>

The drug is currently under evaluation by the United Kingdom's drug regulatory agency for potential utilisation within the National Health Service (NHS).

Also read |&nbsp;<a href="https://www.wionews.com/world/controversial-alzheimers-drug-faces-critical-test-before-fda-panel-341257">Controversial Alzheimer’s drug faces critical test before FDA panel</a>

During the trials, donanemab exhibited a roughly one-third reduction in the progression of the disease.

<h2>Who manufactures donanemab?</h2>

Indianapolis-headquartered Eli Lilly manufactures donanemab, which also operates&nbsp;lecanemab, a drug developed by Eisai and Biogen that gained global attention for its proven ability to slow down the disease.

Also watch |&nbsp;Gravitas: Europe battling drug shortag

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/gravitas-europe-battling-drug-shortage-560129/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

While these drugs hold great promise, it is important to note that they are not without risks.

<h2>Donanemab breakthrough: Risks associated</h2>

Brain swelling emerged as a common side effect affecting up to a third of patients in the donanemab trial.

However, for the majority, this issue resolved itself without causing any symptoms. But two participants, and possibly a third, experienced fatal brain swelling as a result.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

A breakthrough drug known as donanemab has emerged as a significant milestone in the battle against chronic forgetfulness or Alzheimer's disease, after a global trial that confirmed its ability to slow down cognitive decline.

A breakthrough drug known as donanemab has emerged as a significant milestone in the battle against chronic forgetfulness or Alzheimer's disease, after a global trial that confirmed its ability to slow down cognitive decline. The US pharmaceuticals group Eli Lilly on Monday reported full findings of its phase 3 clinical study of donanemab at the Alzheimer’s Association International Conference in Amsterdam. The results showed that the antibody treatment slowed progression by about 35 per cent in the early stages of the disease. When an individual suffers from dementia, a toxic protein gets accumulated in their brain. The aforementioned medication reportedly aids in the early stages of the disease by eliminating this exact protein. The donanemab trial involved 1,736 participants with an average age of 73. The trial participants had mild to moderate symptoms of Alzheimer’s, with half receiving intravenous infusions of the treatment and half a placebo every four weeks for 18 months. The Eli Lilly drug reportedly slowed the progression of the disease, most effectively in its earlier stages. So, is it a cure for dementia? Not exactly. While the medication does not provide a cure, various charitable organisations asserted that the findings published in the journal JAMA point to a new era in Alzheimer's treatment. The treatment specifically targets Alzheimer's disease and does not demonstrate effectiveness in treating other forms of dementia, such as vascular dementia. What next for donanemab? The drug is currently under evaluation by the United Kingdom's drug regulatory agency for potential utilisation within the National Health Service (NHS). Also read | Controversial Alzheimer’s drug faces critical test before FDA panel During the trials, donanemab exhibited a roughly one-third reduction in the progression of the disease. Who manufactures donanemab? Indianapolis-headquartered Eli Lilly manufactures donanemab, which also operates lecanemab, a drug developed by Eisai and Biogen that gained global attention for its proven ability to slow down the disease. Also watch | Gravitas: Europe battling drug shortag × While these drugs hold great promise, it is important to note that they are not without risks. Donanemab breakthrough: Risks associated Brain swelling emerged as a common side effect affecting up to a third of patients in the donanemab trial. However, for the majority, this issue resolved itself without causing any symptoms. But two participants, and possibly a third, experienced fatal brain swelling as a result. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Eli Lilly's new Alzheimer's drug shows promise of slowing down memory decline

A groundbreaking study conducted by scientists from the United States, United Kingdom, and Uruguay has found that regular napping can keep our brains youthful and improve cognitive functions while reducing the risk of dementia and other diseases. By analysing data from nearly 380,000 individuals aged 40 to 69, researchers investigated the cognitive differences between those who habitually took naps and those who lacked comparable genetic markers for napping, reported Science Alert.&nbsp;

<h2>Larger brains in habitual nappers</h2>

The study revealed that individuals who regularly took naps exhibited larger brains, equivalent to being 2.6 to 6.5 years younger than non-nappers. Lead author Valentina Paz, a neuroscientist at University College London (UCL), states, "Our study points to a causal link between habitual napping and larger total brain volume." Previous research on older adults indicated that daytime napping improved short-term cognition, with nappers outperforming non-nappers in cognitive tests. Although the study did not record the duration of naps, previous findings suggest that naps shorter than 30 minutes are optimal, and earlier naps are less likely to disrupt nighttime sleep.

Also read |<a href="https://www.wionews.com/science/previously-undocumented-effect-of-ivf-uncovered-helps-1-in-5-women-conceive-naturally-second-time-around-606828">&nbsp;Previously undocumented effect of IVF uncovered; helps 1-in-5 women conceive naturally second time around</a>

<h2>The complex question of napping's effects on cognition</h2>

Napping has garnered both positive and negative attention recently, leaving many uncertain about its impact on cognitive health. Age-related decline in response time and memory, as well as common cognitive impairments among the elderly, emphasise the importance of identifying modifiable risk factors such as sleep patterns.

<h2>Genetic factors and brain volume analysis</h2>

One of the authors of the study had previously conducted research on the genetic variants influencing napping tendencies, using data from the UK Biobank. This new study analysed health and cognitive outcomes for individuals with these genetic variants while adjusting the data to mitigate potential biases. By examining brain volume and specific DNA sections linked to napping habits, the researchers employed Mendelian randomisation analysis, a method that identifies genes already known to have health effects and helps uncover other influential factors in observational studies. This approach reduced potential biases from associations between napping and health benefits.

<h2>Untangling the causal relationship between napping and cognitive health</h2>

Lead author Paz highlights the significance of this study, stating, "This is the first study to attempt to untangle the causal relationship between habitual daytime napping and cognitive and structural brain outcomes." Self-reports indicated that 57 per cent&nbsp;of participants rarely or never napped, while 38 per cent reported occasional napping and five per cent&nbsp;stated they usually napped. However, those who usually napped tended to have additional factors such as older age, smoking, diabetes, and cardiovascular disease, which could potentially influence health outcomes.

WATCH WION LIVE HERE:

<iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed" style="width:100%;max-width:560px;" width="560"></iframe>

A groundbreaking study conducted by scientists from the United States, United Kingdom, and Uruguay has found that regular napping can keep our brains youthful and improve cognitive functions while reducing the risk of dementia and other diseases.

A groundbreaking study conducted by scientists from the United States, United Kingdom, and Uruguay has found that regular napping can keep our brains youthful and improve cognitive functions while reducing the risk of dementia and other diseases. By analysing data from nearly 380,000 individuals aged 40 to 69, researchers investigated the cognitive differences between those who habitually took naps and those who lacked comparable genetic markers for napping, reported Science Alert. Larger brains in habitual nappers The study revealed that individuals who regularly took naps exhibited larger brains, equivalent to being 2.6 to 6.5 years younger than non-nappers. Lead author Valentina Paz, a neuroscientist at University College London (UCL), states, "Our study points to a causal link between habitual napping and larger total brain volume." Previous research on older adults indicated that daytime napping improved short-term cognition, with nappers outperforming non-nappers in cognitive tests. Although the study did not record the duration of naps, previous findings suggest that naps shorter than 30 minutes are optimal, and earlier naps are less likely to disrupt nighttime sleep. Also read | Previously undocumented effect of IVF uncovered; helps 1-in-5 women conceive naturally second time around The complex question of napping's effects on cognition Napping has garnered both positive and negative attention recently, leaving many uncertain about its impact on cognitive health. Age-related decline in response time and memory, as well as common cognitive impairments among the elderly, emphasise the importance of identifying modifiable risk factors such as sleep patterns. Genetic factors and brain volume analysis One of the authors of the study had previously conducted research on the genetic variants influencing napping tendencies, using data from the UK Biobank. This new study analysed health and cognitive outcomes for individuals with these genetic variants while adjusting the data to mitigate potential biases. By examining brain volume and specific DNA sections linked to napping habits, the researchers employed Mendelian randomisation analysis, a method that identifies genes already known to have health effects and helps uncover other influential factors in observational studies. This approach reduced potential biases from associations between napping and health benefits. Untangling the causal relationship between napping and cognitive health Lead author Paz highlights the significance of this study, stating, "This is the first study to attempt to untangle the causal relationship between habitual daytime napping and cognitive and structural brain outcomes." Self-reports indicated that 57 per cent of participants rarely or never napped, while 38 per cent reported occasional napping and five per cent stated they usually napped. However, those who usually napped tended to have additional factors such as older age, smoking, diabetes, and cardiovascular disease, which could potentially influence health outcomes. WATCH WION LIVE HERE:

Power napping could be a simple solution to lower dementia risk: Study

Bruce Willis' daughter has written an emotional letter on her father's struggle with dementia about four months after his family announced the illness.

Hollywood star Bruce Willis' daughter Tallulah talks about her father's daily battle with dementia

Rosalynn Carter, former US first lady, has dementia, the Carter family said on Tuesday (May 30).

"She continues to live happily at home with her husband, enjoying spring in Plains (Georgia) and visits with loved ones," the family said in a statement.

Carter (95) is the wife of former US president Jimmy Carter (98), who has been receiving hospice care since mid-February at their home. The Carter family said it hoped that making information about Rosalynn Carter's dementia public&nbsp;would help lessen the stigma surrounding the condition.

"We hope sharing our family's news will increase important conversations at kitchen tables and in doctor's offices around the country," they said.

"We do not expect to comment further and ask for understanding for our family and for everyone across the country serving in a caregiver role," they added.

Jimmy Carter's nonprofit foundation announced on February 18 that after several hospital stays the former president and Nobel peace laureate had decided to spend his "remaining time" at home.

After that, the Carters have been visiting only family and close friends.&nbsp;

In the statement, the family has not shared any more specifics about the condition of Rosalynn or Jimmy Carter.

<h2>A long life together</h2>

Married on July 7, 1946, the Carters are the longest-married first couple in US history. There have been married for nearly 77 years. They have often described themselves as 'full partners' throughout Jimmy Carter's political career and public life afterward. Rosalynn Carter spent her long public life advocating for those affected by mental illnesses and also for those who are caregivers in their respective relationships.

“Mrs. Carter often noted that there are only four kinds of people in this world: those who have been caregivers; those who are currently caregivers, those who will be caregivers, and those who will need caregivers,” the statement reads. “The universality of caregiving is clear in our family, and we are experiencing the joy and the challenges of this journey.”

Rosalynn Carter vigorously campaigned for her husband as he made bid to become Georgia governor and the presidency. She used the platform to prioritise mental health awareness as well.

Elenor Rosalynn Smith was born in Plains on August 18, 1924. Incidentally, Jimmy Carter's mother, who was a nurse, delivered her in her family's home. Then after a few days Lillian Carter brought Jimmy to meet the newborn. Thus, the future president and the first lady met as preschooler&nbsp;and a newborn. 
 
WATCH WION LIVE HERE

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false"><iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Rosalynn Carter, former US first lady, has dementia, the Carter family said on Tuesday (May 30). "She continues to live happily at home with her husband, enjoying spring in Plains (Georgia) and visits with loved ones," the family said in a statement.

Rosalynn Carter, former US first lady, has dementia, the Carter family said on Tuesday (May 30). "She continues to live happily at home with her husband, enjoying spring in Plains (Georgia) and visits with loved ones," the family said in a statement. Carter (95) is the wife of former US president Jimmy Carter (98), who has been receiving hospice care since mid-February at their home. The Carter family said it hoped that making information about Rosalynn Carter's dementia public would help lessen the stigma surrounding the condition. "We hope sharing our family's news will increase important conversations at kitchen tables and in doctor's offices around the country," they said. "We do not expect to comment further and ask for understanding for our family and for everyone across the country serving in a caregiver role," they added. Jimmy Carter's nonprofit foundation announced on February 18 that after several hospital stays the former president and Nobel peace laureate had decided to spend his "remaining time" at home. After that, the Carters have been visiting only family and close friends. In the statement, the family has not shared any more specifics about the condition of Rosalynn or Jimmy Carter. A long life together Married on July 7, 1946, the Carters are the longest-married first couple in US history. There have been married for nearly 77 years. They have often described themselves as 'full partners' throughout Jimmy Carter's political career and public life afterward. Rosalynn Carter spent her long public life advocating for those affected by mental illnesses and also for those who are caregivers in their respective relationships. “Mrs. Carter often noted that there are only four kinds of people in this world: those who have been caregivers; those who are currently caregivers, those who will be caregivers, and those who will need caregivers,” the statement reads. “The universality of caregiving is clear in our family, and we are experiencing the joy and the challenges of this journey.” Rosalynn Carter vigorously campaigned for her husband as he made bid to become Georgia governor and the presidency. She used the platform to prioritise mental health awareness as well. Elenor Rosalynn Smith was born in Plains on August 18, 1924. Incidentally, Jimmy Carter's mother, who was a nurse, delivered her in her family's home. Then after a few days Lillian Carter brought Jimmy to meet the newborn. Thus, the future president and the first lady met as preschooler and a newborn. WATCH WION LIVE HERE × You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Carter family says former US First Lady Rosalynn Carter has dementia

A 95-year-old dementia patient who was tasered by a police officer in New South Wales, Australia, last week remains in a “heavy sleep” and is comfortable, surrounded by her family, the Guardian reported.

Clare Nowland is receiving end-of-life care in Cooma district hospital and continues to remain in critical condition with head injuries sustained as she fell back after being hit by a taser.

On Sunday, she was surrounded by her family and well-wishers who held prayers for her wellbeing which were conducted by parish priest Mark Croker sleep.

“At the same time, I think she knows that family are around her and one of them said in the last couple of days she took one of the family members’ hand and just kissed them on the hand,” Croker told the Guardian.

“A couple of times she has squeezed the hand of one of the family’s members. She is comfortable anyway, that is the main point.”

Croker said that the family is aware of the realities of her condition.

“I think they’re realistic and that Mum’s probably instilled that into them in their faith and belief in a life beyond here,” he said.

<h2>Police maintain stoic silence </h2>

Questions are being raised about the police officer’s action. Many are calling for a broader independent investigation of police treatment of dementia sufferers after a report by the Guardian revealed that six officers handcuffed a second nursing home resident, Rachel Grahame, in 2020 after she took a staff member’s lanyard.

Criticism was particularly directed against New South Wales police commissioner Karen Webb, who made no reference to the tasering incident in the initial statement released by police in the Nowland case.

The statement had only mentioned that there had been an “incident” between the nonagenarian and officers.

Defending the decision, Webb on Monday said, “It was necessary for us to make sure that the family were aware of what the circumstances were.”

“We didn’t want the family to hear on radio and TV what had happened to their mum, so we had to be a bit sensitive to that and when we were able to talk about it, we did,” she added.

The incident took place on Wednesday morning after police were called to the Yallambee Lodge aged care home in Cooma after Nowland was found by staff holding a steak knife.

After officers failed to get the 43 kg woman to drop the knife, an experienced officer with 12 years in the service used the Taser on her, causing Nowland to fall and hit her head.

(With inputs from agencies)

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

A 95-year-old dementia patient who was tasered by a police officer in New South Wales, Australia, last week remains in a “heavy sleep” and is comfortable, surrounded by her family, the Guardian reported.

A 95-year-old dementia patient who was tasered by a police officer in New South Wales, Australia, last week remains in a “heavy sleep” and is comfortable, surrounded by her family, the Guardian reported. Clare Nowland is receiving end-of-life care in Cooma district hospital and continues to remain in critical condition with head injuries sustained as she fell back after being hit by a taser. On Sunday, she was surrounded by her family and well-wishers who held prayers for her wellbeing which were conducted by parish priest Mark Croker sleep. “At the same time, I think she knows that family are around her and one of them said in the last couple of days she took one of the family members’ hand and just kissed them on the hand,” Croker told the Guardian. “A couple of times she has squeezed the hand of one of the family’s members. She is comfortable anyway, that is the main point.” Croker said that the family is aware of the realities of her condition. “I think they’re realistic and that Mum’s probably instilled that into them in their faith and belief in a life beyond here,” he said. Police maintain stoic silence Questions are being raised about the police officer’s action. Many are calling for a broader independent investigation of police treatment of dementia sufferers after a report by the Guardian revealed that six officers handcuffed a second nursing home resident, Rachel Grahame, in 2020 after she took a staff member’s lanyard. Criticism was particularly directed against New South Wales police commissioner Karen Webb, who made no reference to the tasering incident in the initial statement released by police in the Nowland case. The statement had only mentioned that there had been an “incident” between the nonagenarian and officers. Defending the decision, Webb on Monday said, “It was necessary for us to make sure that the family were aware of what the circumstances were.” “We didn’t want the family to hear on radio and TV what had happened to their mum, so we had to be a bit sensitive to that and when we were able to talk about it, we did,” she added. The incident took place on Wednesday morning after police were called to the Yallambee Lodge aged care home in Cooma after Nowland was found by staff holding a steak knife. After officers failed to get the 43 kg woman to drop the knife, an experienced officer with 12 years in the service used the Taser on her, causing Nowland to fall and hit her head. (With inputs from agencies)

Clare Nowland: 95-year-old dementia patient tasered by Australian police still critical, but stable

A 95-year-old woman, who is a patient with dementia, suffered life-threatening injuries after she was tasered by a police officer at a care home in Australia. 
 
The woman was admitted to the hospital. Police officers reached Yallambee Lodge in Cooma after they received reports of Clare Nowland carrying a knife. 
 
The incident sparked an outcry as advocates called the action of police officers a “disproportionate response”. The New South Wales (NSW) police chief stated that she shares the concerns raised by the community and that an investigation is going on. 
 
The police officers found Nowland in her room "armed" with a steak knife on Wednesday morning, said Assistant Police Commissioner Peter Cotter, while speaking to media on Friday.

ALSO READ | <a href="https://www.wionews.com/world/who-is-mailing-used-condoms-to-australian-women-police-open-up-investigation-593154">Who is mailing used condoms to Australian women? Police open investigation&nbsp;</a>

 
He added that the care home staff and police officers made efforts to de-escalate the situation. 
 
"At the time she was tasered, she was approaching police but it is fair to say at a slow pace. She had a walking frame, but she had a knife,” said Cotter during a press conference. 
 
Nowland's family friend Andrew Thaler claimed she was struck twice, in the back and the chest, after which she fell and suffered a fractured skull as well as a serious brain bleed.

<h2>'Family fears woman may not survive' 
&nbsp;</h2>

Her family has been grieving about the injuries she has suffered and fear that the woman may not survive, Thaler said while speaking to the BBC. 
 
"The family are shocked, they're confused... and the community is outraged. How can this happen? How do you explain this level of force? It's absurd,” he added. 
 
Community groups, which include People with Disability Australia (PwD) and NSW Council for Civil Liberties, have criticised the response of the police. 
 
"She's either one hell of an agile, fit, fast and intimidating 95-year-old woman, or there's a very poor lack of judgement (from) those police officers," said PwD President Nicole Lee while speaking to the Australian Broadcasting Corporation. 
 
"She needed somebody to... handle her with compassion and time, and not Tasers,” he added. 
 
An investigation into the critical incident has been launched by NSW Police which Commissioner Karen Webb stated is being treated with "the utmost seriousness".

"I understand and share the community concerns," she stated.

WATCH | Australia: New immigration policy makes it easier to retain international students

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/australia-new-immigration-policy-makes-it-easier-to-retain-international-students-586619/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

 
The officer who was involved in the incident has not been suspended by the department but will be interrogated as part of the ongoing investigation. The investigation will also include the homicide squad. 
 
"No officer, not one of us, is above the law. All our actions will be scrutinised robustly from a criminal perspective as well,” Cotter stated. 
 
Snowy Monaro Regional Council, which runs the care home, has defended its response.

<main>
<section>
You can&nbsp;now write for&nbsp;wionews.com&nbsp;and be a part of the community. Share your stories and opinions with us&nbsp;<a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>
</section>
</main>

A 95-year-old woman, who is a patient with dementia, suffered life-threatening injuries after she was tasered by a police officer at a care home in Australia. The woman was admitted to the hospital.

A 95-year-old woman, who is a patient with dementia, suffered life-threatening injuries after she was tasered by a police officer at a care home in Australia. The woman was admitted to the hospital. Police officers reached Yallambee Lodge in Cooma after they received reports of Clare Nowland carrying a knife. The incident sparked an outcry as advocates called the action of police officers a “disproportionate response”. The New South Wales (NSW) police chief stated that she shares the concerns raised by the community and that an investigation is going on. The police officers found Nowland in her room "armed" with a steak knife on Wednesday morning, said Assistant Police Commissioner Peter Cotter, while speaking to media on Friday. ALSO READ | Who is mailing used condoms to Australian women? Police open investigation He added that the care home staff and police officers made efforts to de-escalate the situation. "At the time she was tasered, she was approaching police but it is fair to say at a slow pace. She had a walking frame, but she had a knife,” said Cotter during a press conference. Nowland's family friend Andrew Thaler claimed she was struck twice, in the back and the chest, after which she fell and suffered a fractured skull as well as a serious brain bleed. 'Family fears woman may not survive' Her family has been grieving about the injuries she has suffered and fear that the woman may not survive, Thaler said while speaking to the BBC. "The family are shocked, they're confused... and the community is outraged. How can this happen? How do you explain this level of force? It's absurd,” he added. Community groups, which include People with Disability Australia (PwD) and NSW Council for Civil Liberties, have criticised the response of the police. "She's either one hell of an agile, fit, fast and intimidating 95-year-old woman, or there's a very poor lack of judgement (from) those police officers," said PwD President Nicole Lee while speaking to the Australian Broadcasting Corporation. "She needed somebody to... handle her with compassion and time, and not Tasers,” he added. An investigation into the critical incident has been launched by NSW Police which Commissioner Karen Webb stated is being treated with "the utmost seriousness". "I understand and share the community concerns," she stated. WATCH | Australia: New immigration policy makes it easier to retain international students The officer who was involved in the incident has not been suspended by the department but will be interrogated as part of the ongoing investigation. The investigation will also include the homicide squad. "No officer, not one of us, is above the law. All our actions will be scrutinised robustly from a criminal perspective as well,” Cotter stated. Snowy Monaro Regional Council, which runs the care home, has defended its response. You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here. WATCH WION LIVE HERE

Australia: Police face outcry after officer tasers 95-year-old woman holding knife

dementia

Dementia, News on Dementia, stories on Dementia, articles on Dementia, Dementia stories at Wion, Dementia news, Dementia latest news